let question = {
  "data": {
    "events": {
      "event": [
        {
          "rollover": {
            "css": "this"
          },
          "rollout": {
            "css": "this"
          }
        },
        {
          "rollover": {
            "css": "this"
          },
          "rollout": {
            "css": "this"
          }
        },
        {
          "click": {
            "css": "this",
            "function": [
              "this",
              "this"
            ]
          }
        },
        {
          "click": {
            "css": "this",
            "function": "this"
          }
        },
        {
          "click": {
            "function": "this"
          }
        },
        {
          "click": {
            "function": "this"
          }
        },
        {
          "click": {
            "anim": "openingText",
            "function": "this"
          }
        },
        {
          "click": {
            "function": "this"
          }
        },
        {
          "click": {
            "function": "this"
          }
        },
        {
          "click": {
            "function": "this"
          }
        },
        {
          "click": {
            "function": "this"
          }
        },
        {
          "click": {
            "anim": "q1bg"
          }
        },
        {
          "click": {
            "anim": "passbg"
          }
        },
        {
          "click": {
            "anim": "passbg"
          }
        },
        {
          "click": {
            "anim": "failbg"
          }
        },
        {
          "click": {
            "anim": "failbg"
          }
        },
        {
          "click": {
            "css": "this",
            "function": "this"
          }
        },
        {
          "click": {
            "css": "this",
            "function": "this"
          }
        }
      ]
    },
    "box": [
      "",
      "",
      {
        "box": [
          "",
          ""
        ]
      },
      {
        "text": {
          "__cdata": "<h1 class=\"black\">Prometric MCQ - HEMATOLOGY-ONCOLOGY - Section - 01</h1><p class=\"p_20_black\">Welcome to MedicalMCQ4All.com</p><p class=\"p_20_black\"><h3><span style=\"color: rgb(230, 0, 0);\">IMPORTANT MCQS LIST- You must know the below MCQs for your Exam preparations </span></h3><p><strong style=\"color: rgb(61, 20, 102);\">Must read -Quick Review points on our website it's free on your package.</strong></p><p><strong style=\"color: rgb(61, 20, 102);\">For Personalised or group coaching online or crash course subject wise-please contact </strong></p><p><strong style=\"color: rgb(61, 20, 102);\">Mobile/Whatsapp/BOTIM/IMO on +91 9825578080 (Dr.Munjal Pandya)</strong></p><p><strong style=\"color: rgb(61, 20, 102);\">Contact for DATAFLOW on same above numbers</strong></p><p><strong style=\"color: rgb(61, 20, 102);\">Skype-munjal.pandya1</strong></p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">﻿HEMATOLOGY MCQS</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q1-CLL and Staging(Rai classification)</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q2-AML- confirmatory test</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q4-Megaloblastic anemia Diagnosis</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q8-B12 Peripheral Smear</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q11-Sickle cell disease and Hemoglobin electrophoresis</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q31- Hodgkins vs Non-Hodgkin's Lymphoma</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q34-How to Differentiate Leukemias</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q35-Sickle cell and Retic count</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q44- ITP(Immune Thrombocytopenic Purpura)</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q60-Myeloma diagnosis</strong></p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">ONCOLOGY MCQS</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q3-Postmenopausal -Endometrial biopsy</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q19-CA 125 -Ovarian Cancer</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q28-Colon cancer</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q36-PAP smear</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q39-Cervical cancer</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q40-Bisphosphonate and osteoporosis</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q66-Lung Cancer</strong></p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">FEW BREAST BENIGN AND CANCER-RELATED HIGH YIELD MCQs</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q6-Breast cancer prognostic factors</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q30-Breast cancer prognostic factor</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q41-Fibroadenoma</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q43-Breast cancer Management</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q69-Phylloid breast</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q70-Paget's disease of the breast</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q74-Breast cancer common histology</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q84-Fibroadenoma</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q85- Breast cancer</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q93-Mammogram reduce mortality highest</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q98-Breast cancer treatment</strong></p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">CANCER SCREENING MCQs</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q3-Post menopausal bleeding-Endometrial cancer</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q19-Tumour markers </strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q28-Colon cancer </strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q36-PAP smear</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q39-Cervical cancer</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q66-Lung cancer</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q83-Lung cancer screening</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q89-Colonoscopy</strong></p><p><strong style=\"color: rgb(0, 102, 204);\">Q93-Breast cancer Mortality advantage by Mammography</strong></p><p><br></p><p><br></p></p>"
        },
        "button": {
          "__cdata": "Let's go!"
        }
      }
    ],
    "custom": {
      "settings": "",
      "question": [
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">1. In CLL (Chronic Lymphoblastic Leukaemia) patient  has Hb 13gm%, WBC count 80, 000/cumm, Lymphocyte is 90% ,Peripheral smear showed Mature looking lymphocytes,Platelet-2, 00,000/cumm.on examination no lymphadenopathy, no organomegaly. what is the stage of CLL?</p>"
          },
          "image": [
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/28ba9541e873e7dd244ce48565557d92.png"
            },
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/7f0ebfcc98f520b0bf95e71f6637b3ab.jpg"
            }
          ],
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. stage 1</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Stage 2</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Stage 3</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Stage 4</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. stage -0</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is E : stage -0<br/><p>Rai stage grouping Stage 0: The patient has lymphocytosis with more than 5000 lymphocytes per microliter of blood, but no other physical signs.</p><p><strong style=\"color: rgb(230, 0, 0);\">Stage I:</strong> The patient has lymphocytosis and enlarged lymph nodes. The patient does not have an enlarged liver or spleen, anemia, or low levels of platelets. <strong style=\"color: rgb(230, 0, 0);\">Stage II:</strong> The patient has lymphocytosis and an enlarged spleen and/or liver and may or may not have swollen lymph nodes.</p><p><strong style=\"color: rgb(230, 0, 0);\">Stage III</strong>: The patient has lymphocytosis and anemia. The patient may or may not have swollen lymph nodes and an enlarged liver or spleen.</p><p><strong style=\"color: rgb(230, 0, 0);\">Stage IV:</strong> The patient has lymphocytosis and low levels of platelets. The patient may or may not have swollen lymph nodes, an enlarged liver or spleen, or anemia.</p><p><br></p><p>CLL-</p><p><strong style=\"color: rgb(147, 59, 3);\">Presentation </strong></p><p><span style=\"color: rgb(0, 0, 0);\">Chronic lymphocytic leukemia (CLL) is a clonal proliferation of normal, mature-appearing B lymphocytes that function abnormally. CLL occurs age &gt;50 </span></p><p><span style=\"color: rgb(0, 0, 0);\">in 90% of those affected. Many are </span><strong style=\"color: rgb(0, 0, 0);\">asymptomatic </strong><span style=\"color: rgb(0, 0, 0);\">at presentation with only a markedly elevated white blood cell count. The </span><strong style=\"color: rgb(0, 0, 0);\">most common symptom is </strong></p><p><strong style=\"color: rgb(0, 0, 0);\">fatigue</strong><span style=\"color: rgb(0, 0, 0);\">. Other symptoms include:&nbsp;</span></p><ul><li><strong style=\"color: rgb(0, 0, 0);\">Lymphadenopathy </strong><span style=\"color: rgb(0, 0, 0);\">(80%) </span></li><li><strong style=\"color: rgb(0, 0, 0);\">Spleen or liver enlargement </strong><span style=\"color: rgb(0, 0, 0);\">(50%) </span></li><li><strong style=\"color: rgb(0, 0, 0);\">Infection </strong><span style=\"color: rgb(0, 0, 0);\">from poor lymphocyte function </span></li><li><strong style=\"color: rgb(0, 0, 0);\">Hemolysis </strong><span style=\"color: rgb(0, 0, 0);\">sometimes&nbsp;</span></li></ul><p><strong style=\"color: rgb(230, 0, 0);\">Diagnisis-CBC shows</strong></p><p><span style=\"color: rgb(0, 0, 0);\">The WBC count is usually at least above 20,000/?L with 80% to 98% lymphocytes. Half of patients are </span><strong style=\"color: rgb(0, 0, 0);\">hypogammaglobulinemic</strong><span style=\"color: rgb(0, 0, 0);\">.</span></p><p><span style=\"color: rgb(0, 0, 0);\">Anemia and thrombocytopenia can occur from marrow infiltration or autoimmune warm IgG antibodies. CLL is paradoxical. When the body needs a </span></p><p><span style=\"color: rgb(0, 0, 0);\">useful antibody for an infection, it is often not made; on the other hand, the CLL cells attack normal red blood cells and platelets.&nbsp;</span></p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">Treatment</strong></p><p><span style=\"color: rgb(0, 0, 0);\">For stage 0 (elevated WBC), stage I (lymphadenopathy), and stage II (hepatosplenomegaly), there is no treatment.&nbsp;</span></p><p><span style=\"color: rgb(0, 0, 0);\">Stage III ( anemia) and stage IV ( thrombocytopenia) are treated with fludarabine, cyclophosphamide, and rituximab.&nbsp;</span></p><p><strong style=\"color: rgb(0, 0, 0);\">TIPS</strong></p><p><strong style=\"color: rgb(230, 0, 0);\">CLL has no unique physical findings</strong><span style=\"color: rgb(0, 0, 0);\">.&nbsp;</span></p>.</p>"
                },
                "button": {
                  "__cdata": "Next"
                }
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is E : stage -0<br/><p>Rai stage grouping Stage 0: The patient has lymphocytosis with more than 5000 lymphocytes per microliter of blood, but no other physical signs.</p><p><strong style=\"color: rgb(230, 0, 0);\">Stage I:</strong> The patient has lymphocytosis and enlarged lymph nodes. The patient does not have an enlarged liver or spleen, anemia, or low levels of platelets. <strong style=\"color: rgb(230, 0, 0);\">Stage II:</strong> The patient has lymphocytosis and an enlarged spleen and/or liver and may or may not have swollen lymph nodes.</p><p><strong style=\"color: rgb(230, 0, 0);\">Stage III</strong>: The patient has lymphocytosis and anemia. The patient may or may not have swollen lymph nodes and an enlarged liver or spleen.</p><p><strong style=\"color: rgb(230, 0, 0);\">Stage IV:</strong> The patient has lymphocytosis and low levels of platelets. The patient may or may not have swollen lymph nodes, an enlarged liver or spleen, or anemia.</p><p><br></p><p>CLL-</p><p><strong style=\"color: rgb(147, 59, 3);\">Presentation </strong></p><p><span style=\"color: rgb(0, 0, 0);\">Chronic lymphocytic leukemia (CLL) is a clonal proliferation of normal, mature-appearing B lymphocytes that function abnormally. CLL occurs age &gt;50 </span></p><p><span style=\"color: rgb(0, 0, 0);\">in 90% of those affected. Many are </span><strong style=\"color: rgb(0, 0, 0);\">asymptomatic </strong><span style=\"color: rgb(0, 0, 0);\">at presentation with only a markedly elevated white blood cell count. The </span><strong style=\"color: rgb(0, 0, 0);\">most common symptom is </strong></p><p><strong style=\"color: rgb(0, 0, 0);\">fatigue</strong><span style=\"color: rgb(0, 0, 0);\">. Other symptoms include:&nbsp;</span></p><ul><li><strong style=\"color: rgb(0, 0, 0);\">Lymphadenopathy </strong><span style=\"color: rgb(0, 0, 0);\">(80%) </span></li><li><strong style=\"color: rgb(0, 0, 0);\">Spleen or liver enlargement </strong><span style=\"color: rgb(0, 0, 0);\">(50%) </span></li><li><strong style=\"color: rgb(0, 0, 0);\">Infection </strong><span style=\"color: rgb(0, 0, 0);\">from poor lymphocyte function </span></li><li><strong style=\"color: rgb(0, 0, 0);\">Hemolysis </strong><span style=\"color: rgb(0, 0, 0);\">sometimes&nbsp;</span></li></ul><p><strong style=\"color: rgb(230, 0, 0);\">Diagnisis-CBC shows</strong></p><p><span style=\"color: rgb(0, 0, 0);\">The WBC count is usually at least above 20,000/?L with 80% to 98% lymphocytes. Half of patients are </span><strong style=\"color: rgb(0, 0, 0);\">hypogammaglobulinemic</strong><span style=\"color: rgb(0, 0, 0);\">.</span></p><p><span style=\"color: rgb(0, 0, 0);\">Anemia and thrombocytopenia can occur from marrow infiltration or autoimmune warm IgG antibodies. CLL is paradoxical. When the body needs a </span></p><p><span style=\"color: rgb(0, 0, 0);\">useful antibody for an infection, it is often not made; on the other hand, the CLL cells attack normal red blood cells and platelets.&nbsp;</span></p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">Treatment</strong></p><p><span style=\"color: rgb(0, 0, 0);\">For stage 0 (elevated WBC), stage I (lymphadenopathy), and stage II (hepatosplenomegaly), there is no treatment.&nbsp;</span></p><p><span style=\"color: rgb(0, 0, 0);\">Stage III ( anemia) and stage IV ( thrombocytopenia) are treated with fludarabine, cyclophosphamide, and rituximab.&nbsp;</span></p><p><strong style=\"color: rgb(0, 0, 0);\">TIPS</strong></p><p><strong style=\"color: rgb(230, 0, 0);\">CLL has no unique physical findings</strong><span style=\"color: rgb(0, 0, 0);\">.&nbsp;</span></p>.</p>"
                },
                "button": {
                  "__cdata": "Next"
                }
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">2. Which is the most confirmatory test for Acute Myeloid Leukemia (AML/Blood cancer)?<br />\nClick below image to enlarge view.Arrow shows Auer rods in Blast cells</p>"
          },
          "image": [
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/849fcca800aa4dd427fee93359d9e591.png"
            },
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/b19e43bc50f41abcd069f78b549ecef1.jpg"
            }
          ],
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Bone marrow examination</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Flow cytometry/Immunophenotyping</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Cytogenetics/Chromosomal analysis</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. PCR test</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Flow cytometry/Immunophenotyping<br/><p>Flow cytometry/Immunophenotyping is diagnostic and specific. test to diagnose and differentiate Leukaemia.bone marrow is initial test which is mandatory but many a time difficult to differential between myeloid or lymphoid or AML or ALL …so surface marker known as CD markers used for exact diagnosis ..treatment differs of all leukemias so practicaly every physician /hematologist doing Immunophenotyping or flowcytometry before starting leukemia treatment.Cytogenetics/chromosomal analysis is for prognostic value and on cytogenetics and Molecular markers,most leukemia categorised as good ,intermediate or high risk and depends on risk stratifications treatment plan can change.</p><p>TIPS for ALL leukemia</p><p>1- Initial test-CBC and peripheral smear</p><p>2-Diagnostic test-Bone marrow aspirate and biopsy</p><p>3-Confirmatory test- Immunophenotyping or flow cytometry</p><p>4- Prognostic test-Cytogenetic</p><p><a href=\"http://cancerres.aacrjournals.org/content/61/11/4483.full\" target=\"_blank\">http://cancerres.aacrjournals.org/content/61/11/4483.full</a></p><p><br></p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">TIPS</strong></p><ul><li>presence of more than 20% blast in blood or bone marrow suggest Acute Leukemia</li><li>Flow cytometry test is preferable do from Bone marrow but can be done from peripheral blood also</li><li>AML has M0 to M0 subtype</li><li>AML M3 also known as Acute Promyelocytic Leukemia(APL),presents with DIC and has highest mortality rate if untreated</li><li>AML M3 has best cure rate around 70-80%</li><li>Treatment of ALL subtype of AML is same like chemotherapy but AML M3 is treated with ATRA(All trans retinoic acid) and chemotherapy</li><li>PML RAR alpha is oncogene responsible for AML</li><li>t(15,17) commonest cytogenetic abnormalities can be seen in AML.</li></ul>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Flow cytometry/Immunophenotyping<br/><p>Flow cytometry/Immunophenotyping is diagnostic and specific. test to diagnose and differentiate Leukaemia.bone marrow is initial test which is mandatory but many a time difficult to differential between myeloid or lymphoid or AML or ALL …so surface marker known as CD markers used for exact diagnosis ..treatment differs of all leukemias so practicaly every physician /hematologist doing Immunophenotyping or flowcytometry before starting leukemia treatment.Cytogenetics/chromosomal analysis is for prognostic value and on cytogenetics and Molecular markers,most leukemia categorised as good ,intermediate or high risk and depends on risk stratifications treatment plan can change.</p><p>TIPS for ALL leukemia</p><p>1- Initial test-CBC and peripheral smear</p><p>2-Diagnostic test-Bone marrow aspirate and biopsy</p><p>3-Confirmatory test- Immunophenotyping or flow cytometry</p><p>4- Prognostic test-Cytogenetic</p><p><a href=\"http://cancerres.aacrjournals.org/content/61/11/4483.full\" target=\"_blank\">http://cancerres.aacrjournals.org/content/61/11/4483.full</a></p><p><br></p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">TIPS</strong></p><ul><li>presence of more than 20% blast in blood or bone marrow suggest Acute Leukemia</li><li>Flow cytometry test is preferable do from Bone marrow but can be done from peripheral blood also</li><li>AML has M0 to M0 subtype</li><li>AML M3 also known as Acute Promyelocytic Leukemia(APL),presents with DIC and has highest mortality rate if untreated</li><li>AML M3 has best cure rate around 70-80%</li><li>Treatment of ALL subtype of AML is same like chemotherapy but AML M3 is treated with ATRA(All trans retinoic acid) and chemotherapy</li><li>PML RAR alpha is oncogene responsible for AML</li><li>t(15,17) commonest cytogenetic abnormalities can be seen in AML.</li></ul>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">3. 60 year lady on oral contraceptive pills 21 days a month having recurrent vaginal bleeding (spotting) after the stopping of estrogen, What is the best next step is to do ?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Do endometrial biopsy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. PAP smears of cervix</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Add progesterone</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Stop estrogen</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Abdominal US and laproscopy</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Do endometrial biopsy<br/>Estrogen therapy or ET<br />\nTreating menopausal symptoms with estrogen alone is known as estrogen therapy (ET). ET improves the symptoms of menopause, but it increases the risk of cancer of the uterus (endometrial cancer). Because of this, ET is only safe for women who don’t have a uterus (such as those who have had a hysterectomy).<br />\n<a target=\"_blank\" href=\"https://www.cancer.org/cancer/cancer-causes/medical-treatments/menopausal-hormone-replacement-therapy-and-cancer-risk.html\">https://www.cancer.org/cancer/cancer-causes/medical-treatments/menopausal-hormone-replacement-therapy-and-cancer-risk.html</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Do endometrial biopsy<br/>Estrogen therapy or ET<br />\nTreating menopausal symptoms with estrogen alone is known as estrogen therapy (ET). ET improves the symptoms of menopause, but it increases the risk of cancer of the uterus (endometrial cancer). Because of this, ET is only safe for women who don’t have a uterus (such as those who have had a hysterectomy).<br />\n<a target=\"_blank\" href=\"https://www.cancer.org/cancer/cancer-causes/medical-treatments/menopausal-hormone-replacement-therapy-and-cancer-risk.html\">https://www.cancer.org/cancer/cancer-causes/medical-treatments/menopausal-hormone-replacement-therapy-and-cancer-risk.html</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">4. Young 32 years pure vegetarian, busy businessman, with history of frequently skipping of meals due to his daily busy work schedule. He presented with history of fatigue, occasional dyspnoea on exertion and climbing stairs with weight loss of 2 kg in 3 months, he has no history of fever or bleeding from any site. on examination he has pallor and mild icterus, Rest of examination is essentially normal. His blood workup showed Hb 7gm%, MCV 130fl,Total WBC-3700/cumm,Platelet is 100,000/cumm. Peripheral smears showed hyper segmented neutrophil and macro ovalocytes what is the most  likely diagnosis is?</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/0ef1a37dada6a0bb352091f84d487b16.jpg"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Iron deficiency anemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Hemolytic anemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Megaloblastic anemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Blood loss anemia</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Megaloblastic anemia<br/><p>Macrocytic has MCV more than -100</p><p>Microcytic has MCV less than 80</p><p>Normocytic has normal MCV means 80-100</p><p>Macrocytic anemia has megaloblastic and Non megaloblastic variety</p><p>Megaloblastic includes- B12 and folate dificiency</p><p>Non Megaloblastic has- Liver disease.MDS,Hypothyroidism,Reticulosis where MCV is high but no megaloblastic changes</p><p><br></p><p>in this current scinario History like young,vegeterian,skipping meals</p><p>Labs ,very high MCV,Hypersegmented neutrophil is suggestive of Megaloblastic anemia. Megaloblastic anemia is a condition in which the bone marrow produces unusually large, structurally abnormal, immature red blood cells (megaloblasts).Retic count is low and LDH is very high in most of the cases.</p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">TIPS</strong></p><ul><li><strong style=\"color: rgb(0, 0, 0);\">B12 deficiency can give any neurological abnormality, but peripheral neuropathy is the most common. Dementia is the least common. Posterior column damage to position and vibratory sensation or “subacute combined degeneration” of the cord is classic. Look for ataxia.</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">Only B12 deficiency is associated with an increased methylmalonic acid leve</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">B12 and folate deficiency are identical hematologically and on blood smear.&nbsp;</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">B12 deficiency: High LDH + High bilirubin + Low reticulocytes = Ineffective erythropoiesis&nbsp;</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">Metformin is associated with B12 deficiency</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">B12 can give either neurological or hematological abnormalities alone. You do not have to have both.&nbsp;</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">B12 and folate deficiency can cause pancytopenia as well as MACROCYTIC anemia</strong></li></ul><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Megaloblastic anemia<br/><p>Macrocytic has MCV more than -100</p><p>Microcytic has MCV less than 80</p><p>Normocytic has normal MCV means 80-100</p><p>Macrocytic anemia has megaloblastic and Non megaloblastic variety</p><p>Megaloblastic includes- B12 and folate dificiency</p><p>Non Megaloblastic has- Liver disease.MDS,Hypothyroidism,Reticulosis where MCV is high but no megaloblastic changes</p><p><br></p><p>in this current scinario History like young,vegeterian,skipping meals</p><p>Labs ,very high MCV,Hypersegmented neutrophil is suggestive of Megaloblastic anemia. Megaloblastic anemia is a condition in which the bone marrow produces unusually large, structurally abnormal, immature red blood cells (megaloblasts).Retic count is low and LDH is very high in most of the cases.</p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">TIPS</strong></p><ul><li><strong style=\"color: rgb(0, 0, 0);\">B12 deficiency can give any neurological abnormality, but peripheral neuropathy is the most common. Dementia is the least common. Posterior column damage to position and vibratory sensation or “subacute combined degeneration” of the cord is classic. Look for ataxia.</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">Only B12 deficiency is associated with an increased methylmalonic acid leve</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">B12 and folate deficiency are identical hematologically and on blood smear.&nbsp;</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">B12 deficiency: High LDH + High bilirubin + Low reticulocytes = Ineffective erythropoiesis&nbsp;</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">Metformin is associated with B12 deficiency</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">B12 can give either neurological or hematological abnormalities alone. You do not have to have both.&nbsp;</strong></li><li><strong style=\"color: rgb(0, 0, 0);\">B12 and folate deficiency can cause pancytopenia as well as MACROCYTIC anemia</strong></li></ul><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">5. A newborn baby presented with profuse bleeding from umbilical stump after birth. activated partial thromboplastin time (aPTT) and prothrombin time (PT) are normal. What is the most likely Probable diagnosis?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Factor XIII deficiency</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. VWF deficiency</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Factor XII deficiency</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Glanzmannthrombosthenia</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Factor XIII deficiency<br/>The symptoms and severity of factor XIII deficiency can vary from one person to another. However, in most of the patients (80%) bleeding symptoms appear after birth with bleeding from the umbilical stump being most common. <br />\n<br />\nA diagnosis of factor XIII deficiency is based upon identification of characteristic symptoms, a detailed patient history, a thorough clinical evaluation and a variety of specialized tests. Standard tests used to diagnose bleeding disorders such as activated partial thromboplastin time (aPTT) and prothrombin time (PT) are normal and therefore ineffective. A diagnosis of factor XIII may be suspected in infants that experience heavy or abnormal bleeding at birth.<br />\n<br />\nFactor XIII deficiency is a rare, genetic bleeding disorder characterized by deficiency of clotting factor XIII. Clotting factors are specialized proteins that are essential for the blood to clot properly. Specifically, individuals with factor XIII deficiency form blood clots like normal, but these clots are unstable and often break down, resulting in prolonged, uncontrolled bleeding episodes. Factor XIII also affects other processes in the body and is known to play a role in proper wound healing and pregnancy. The severity of factor XIII deficiency bleeds can vary greatly from one person to another. Some individuals may have only mild symptoms; other individuals may have severe, life-threatening bleeds. With early diagnosis and prompt treatment, the more serious bleeds of factor XIII deficiency can be avoided. FXIII consists of two subunits: subunit A and subunit B. Most of the Factor XIII deficiency states are caused by mutations in subunit A; very few have a mutation in subunit B. Factor XIII deficiency is inherited as an autosomal recessive disorder.<br />\n<br />\n<a target=\"_blank\" href=\"https://rarediseases.org/rare-diseases/factor-xiii-deficiency/\">https://rarediseases.org/rare-diseases/factor-xiii-deficiency/</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Factor XIII deficiency<br/>The symptoms and severity of factor XIII deficiency can vary from one person to another. However, in most of the patients (80%) bleeding symptoms appear after birth with bleeding from the umbilical stump being most common. <br />\n<br />\nA diagnosis of factor XIII deficiency is based upon identification of characteristic symptoms, a detailed patient history, a thorough clinical evaluation and a variety of specialized tests. Standard tests used to diagnose bleeding disorders such as activated partial thromboplastin time (aPTT) and prothrombin time (PT) are normal and therefore ineffective. A diagnosis of factor XIII may be suspected in infants that experience heavy or abnormal bleeding at birth.<br />\n<br />\nFactor XIII deficiency is a rare, genetic bleeding disorder characterized by deficiency of clotting factor XIII. Clotting factors are specialized proteins that are essential for the blood to clot properly. Specifically, individuals with factor XIII deficiency form blood clots like normal, but these clots are unstable and often break down, resulting in prolonged, uncontrolled bleeding episodes. Factor XIII also affects other processes in the body and is known to play a role in proper wound healing and pregnancy. The severity of factor XIII deficiency bleeds can vary greatly from one person to another. Some individuals may have only mild symptoms; other individuals may have severe, life-threatening bleeds. With early diagnosis and prompt treatment, the more serious bleeds of factor XIII deficiency can be avoided. FXIII consists of two subunits: subunit A and subunit B. Most of the Factor XIII deficiency states are caused by mutations in subunit A; very few have a mutation in subunit B. Factor XIII deficiency is inherited as an autosomal recessive disorder.<br />\n<br />\n<a target=\"_blank\" href=\"https://rarediseases.org/rare-diseases/factor-xiii-deficiency/\">https://rarediseases.org/rare-diseases/factor-xiii-deficiency/</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">6. The most important prognostic factor in breast carcinoma is: click below image to enlarge the view</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/0ee547345721d42292bd4cc6ff5d155c.jpg"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Histological grade of the tumor</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Stage of the tumor at the time of diagnosis</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Ethnicity</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Over expression of p53 tumour suppressor gene</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Stage of the tumor at the time of diagnosis<br/><p>Prognostic factors that are considered to be independent variables include lymph node status, tumour size, and estrogen/progesterone receptor (ER/PR) status. Additional factors include grade, presence of lymphovascular invasion, age, and ethnicity. Stage. The stage is the main prognostic factor for breast cancer. ... Breast cancer diagnosed at a later stage has a greater risk of recurrence, so it has a less favourable prognosis. Doctors will consider if cancer has spread to lymph nodes and the size of the tumour when they predict a prognosis. Stage The stage is the main prognostic factor for breast cancer. There is less risk that early-stage breast cancer will come back (recur) so it has a more favourable prognosis. Breast cancer diagnosed at a later stage has a greater risk of recurrence, so it has a less favourable prognosis. Doctors will consider if cancer has spread to lymph nodes and the size of the tumour when they predict a prognosis. </p><p><a href=\"https://www.breastcancer.org/symptoms/diagnosis/staging\" target=\"_blank\">Breast Cancer Stages: 0 Through IV</a></p><p><br></p><p>The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it is and whether or not it has hormone receptors. The stage of the cancer helps you and your doctor:</p><ul><li>figure out your prognosis, the likely outcome of the disease</li><li>decide on the best treatment options for you</li><li>determine if certain clinical trials may be a good option for you</li></ul><p>Breast cancer stage is usually expressed as a number on a scale of 0 through IV — with stage 0 describing non-invasive cancers that remain within their original location and stage IV describing invasive cancers that have spread outside the breast to other parts of the body.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Stage of the tumor at the time of diagnosis<br/><p>Prognostic factors that are considered to be independent variables include lymph node status, tumour size, and estrogen/progesterone receptor (ER/PR) status. Additional factors include grade, presence of lymphovascular invasion, age, and ethnicity. Stage. The stage is the main prognostic factor for breast cancer. ... Breast cancer diagnosed at a later stage has a greater risk of recurrence, so it has a less favourable prognosis. Doctors will consider if cancer has spread to lymph nodes and the size of the tumour when they predict a prognosis. Stage The stage is the main prognostic factor for breast cancer. There is less risk that early-stage breast cancer will come back (recur) so it has a more favourable prognosis. Breast cancer diagnosed at a later stage has a greater risk of recurrence, so it has a less favourable prognosis. Doctors will consider if cancer has spread to lymph nodes and the size of the tumour when they predict a prognosis. </p><p><a href=\"https://www.breastcancer.org/symptoms/diagnosis/staging\" target=\"_blank\">Breast Cancer Stages: 0 Through IV</a></p><p><br></p><p>The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it is and whether or not it has hormone receptors. The stage of the cancer helps you and your doctor:</p><ul><li>figure out your prognosis, the likely outcome of the disease</li><li>decide on the best treatment options for you</li><li>determine if certain clinical trials may be a good option for you</li></ul><p>Breast cancer stage is usually expressed as a number on a scale of 0 through IV — with stage 0 describing non-invasive cancers that remain within their original location and stage IV describing invasive cancers that have spread outside the breast to other parts of the body.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">7. Child with epistaxis, knee swelling, petechia. Labs shows Hb-13 gm%, WBC count 7800/cumm, platelets counts: 70000/cumm, His Liver function test, Ultra sound abdomen and Coagulation profile is normal. What is the most appropriate treatment?<br />\nclick below image to enlarge view</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/c731b63ff31457f8828870923f1e804c.png"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Methotrexate</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Steroids</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. IV immunoglobulin</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Conservative</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Steroids<br/>Steroid-It is a suspected case of ITP(Immune Thrombocytopenic Purpure).ITP presents usually with isolated thrombocytopenia with or without bleeding. First line treatment is steroid.<br />\nITP is diagnosis of exclusion with peripheral thrombocytopenia with increase Megakaryocytes in bone marrow.<br />\n<br />\nPrednisolone oral  is given as 1-2mg/kg/day for 3-4 weeks then taper over 3-4 weeks. Response rate of steroid is around 70-80% in children with acute ITP. Methotrexate is not first line treatment. IVIG is used in life threatening bleeding like intracranial or massive Gastro intestinal bleeding or high risk with platelet less than 10,000/cumm.. when platelet count is more than 50,000 with no bleeding then patient can be monitored conservatively.<br />\n<br><a target=\"_blank\" href=\"https://www.cureus.com/articles/21170-treatments-for-primary-immune-thrombocytopenia-a-review\">https://www.cureus.com/articles/21170-treatments-for-primary-immune-thrombocytopenia-a-review</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Steroids<br/>Steroid-It is a suspected case of ITP(Immune Thrombocytopenic Purpure).ITP presents usually with isolated thrombocytopenia with or without bleeding. First line treatment is steroid.<br />\nITP is diagnosis of exclusion with peripheral thrombocytopenia with increase Megakaryocytes in bone marrow.<br />\n<br />\nPrednisolone oral  is given as 1-2mg/kg/day for 3-4 weeks then taper over 3-4 weeks. Response rate of steroid is around 70-80% in children with acute ITP. Methotrexate is not first line treatment. IVIG is used in life threatening bleeding like intracranial or massive Gastro intestinal bleeding or high risk with platelet less than 10,000/cumm.. when platelet count is more than 50,000 with no bleeding then patient can be monitored conservatively.<br />\n<br><a target=\"_blank\" href=\"https://www.cureus.com/articles/21170-treatments-for-primary-immune-thrombocytopenia-a-review\">https://www.cureus.com/articles/21170-treatments-for-primary-immune-thrombocytopenia-a-review</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">8. A 73-year-old man comes to the office with fatigue that has become progressively worse over the last several months. He is also short of breath when he walks up one flight of stairs. He drinks 4 vodka martinis a day. He has numbness and tingling in his feet. On physical examination he has decreased sensation<br />\nof his feet. His hematocrit is 28% and MCV is 114 fL (elevated).<br />\nWhat is the most appropriate next step in management?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Vitamin B12 level.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Folate level</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Peripheral blood smear.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Schilling test.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Methylmalonic acid level</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Peripheral blood smear.<br/>Although a macrocytic anemia could be from B12 or folate deficiency, direct alcohol effect on the bone marrow, or liver<br />\ndisease, the first step is a peripheral smear. This is to detect hypersegmented neutrophils. Once hypersegmented neutrophils are<br />\nseen, then you would get B12 and folate levels.<br />\n<br />\nTIPS-Megaloblastic anemia is thepresence of hypersegmented neutrophils. Many factors raise the MCV, but only B12 and folate deficiency and antimetabolite medications cause hypersegmentation.<br />\n<br />\nvit B12 deficiency caused by<br />\n-Pernicious anemia<br />\n-Pancreatic insufficiency<br />\n-Dietary deficiency (vegan/strict vegetarian)<br />\n-Crohn disease, celiac, tropical sprue, radiation, or any disease damaging the<br />\nterminal ileum<br />\n-Blind loop syndrome (gastrectomy or gastric bypass for weight loss)<br />\n-Diphyllobothrium latum, HIV, metformin<br />\n<br />\nTIPS-Celiac disease causes B12, folate,and iron deficiency.<br />\n-B12 and folate deficiency are identical hematologically and on blood smear.<br />\nB12 deficiency:High LDH + High bilirubin + Low reticulocytes = Ineffective erythropoiesis.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Peripheral blood smear.<br/>Although a macrocytic anemia could be from B12 or folate deficiency, direct alcohol effect on the bone marrow, or liver<br />\ndisease, the first step is a peripheral smear. This is to detect hypersegmented neutrophils. Once hypersegmented neutrophils are<br />\nseen, then you would get B12 and folate levels.<br />\n<br />\nTIPS-Megaloblastic anemia is thepresence of hypersegmented neutrophils. Many factors raise the MCV, but only B12 and folate deficiency and antimetabolite medications cause hypersegmentation.<br />\n<br />\nvit B12 deficiency caused by<br />\n-Pernicious anemia<br />\n-Pancreatic insufficiency<br />\n-Dietary deficiency (vegan/strict vegetarian)<br />\n-Crohn disease, celiac, tropical sprue, radiation, or any disease damaging the<br />\nterminal ileum<br />\n-Blind loop syndrome (gastrectomy or gastric bypass for weight loss)<br />\n-Diphyllobothrium latum, HIV, metformin<br />\n<br />\nTIPS-Celiac disease causes B12, folate,and iron deficiency.<br />\n-B12 and folate deficiency are identical hematologically and on blood smear.<br />\nB12 deficiency:High LDH + High bilirubin + Low reticulocytes = Ineffective erythropoiesis.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">9. A 73-year-old woman comes with decreased position and vibratory sensation of the lower extremities, a hematocrit of 28%, MCV of 114 fL, and Hypersegmented neutrophils. Her B12 level is decreased, but near the borderline of normal.<br />\nWhat is the most appropriate next step in the management of this patient?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Methylmalonic acid level</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Anti-intrinsic factor antibodies.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Anti-parietal cell antibodies.\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Schillings test</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Folate level.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">F. Homocysteine level</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Methylmalonic acid level<br/>Many exams frequently tests the fact that while both B12 and folate deficiency increase homocysteine levels, only<br />\nB12 is associated with an increased MMA. The B12 level can be normal in as many as a third of patients with B12 deficiency because the carrier protein, transcobalamin, is an acute phase reactant and can be elevated from many forms of stress such as infection, cancer, or trauma. When the story suggests B12 deficiency and the B12 level is equivocal, use an increased MMA level to confirm the diagnosis of vitamin B12 deficiency.<br />\n<br />\nTested facts about macrocytic anemia:<br />\n-Schilling test is never the right answer.<br />\n-Pernicious anemia is confirmed with anti-intrinsic factor and antiparietal cell antibodies.<br />\n-Red blood cells are destroyed as they leave the marrow, so the<br />\nreticulocyte count is low.<br />\n-B12 and folate deficiency can cause pancytopenia as well as macrocytic anemia.<br />\n-Pancreatic enzymes are needed to absorb B12. They free it from carrier proteins.<br />\n-Neurological abnormalities will improve as long as they are minor (e.g., peripheral) and of short duration.<br />\n<br />\nTIPS-B12 can give either neurological or hematological abnormalities alone.<br />\nYou do not have to have both..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Methylmalonic acid level<br/>Many exams frequently tests the fact that while both B12 and folate deficiency increase homocysteine levels, only<br />\nB12 is associated with an increased MMA. The B12 level can be normal in as many as a third of patients with B12 deficiency because the carrier protein, transcobalamin, is an acute phase reactant and can be elevated from many forms of stress such as infection, cancer, or trauma. When the story suggests B12 deficiency and the B12 level is equivocal, use an increased MMA level to confirm the diagnosis of vitamin B12 deficiency.<br />\n<br />\nTested facts about macrocytic anemia:<br />\n-Schilling test is never the right answer.<br />\n-Pernicious anemia is confirmed with anti-intrinsic factor and antiparietal cell antibodies.<br />\n-Red blood cells are destroyed as they leave the marrow, so the<br />\nreticulocyte count is low.<br />\n-B12 and folate deficiency can cause pancytopenia as well as macrocytic anemia.<br />\n-Pancreatic enzymes are needed to absorb B12. They free it from carrier proteins.<br />\n-Neurological abnormalities will improve as long as they are minor (e.g., peripheral) and of short duration.<br />\n<br />\nTIPS-B12 can give either neurological or hematological abnormalities alone.<br />\nYou do not have to have both..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">10. Which one of the following is an absolute contraindication to combined oral contraceptive pill use?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Controlled hypertension</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. History of cholestasis</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. 36-year-old woman smoking 20 cigarettes/day</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. BMI of 38 m2</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Migraine without aura</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : 36-year-old woman smoking 20 cigarettes/day<br/>-because ocp predispose to atherosclerosis...this women smoke 2O cigerate per day so it will increase the likehood of atherosclorsis with ocp.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : 36-year-old woman smoking 20 cigarettes/day<br/>-because ocp predispose to atherosclerosis...this women smoke 2O cigerate per day so it will increase the likehood of atherosclorsis with ocp.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">11. Hemoglobin electrophoresis done for a young adult male patient shows HbA=58%,HbS = 35%, HbA2 = 2%, HbF = 5 %, what is most likely diagnosis?</p>"
          },
          "image": [
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/23b08d34b369b52d12084a27ddac47d9.png"
            },
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/ae7693638464c46c1f1e829de86b781e.jpg"
            }
          ],
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Thalassemia minor</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Thalassemia major</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Sickle cell trait</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Sickle cell anemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Sickle cell thalassemia</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Sickle cell trait<br/><p><span style=\"color: rgb(230, 0, 0);\">What is the difference between sickle cell disease and trait? </span></p><p><strong>People with sickle cell trait (AS) </strong>inherit one gene for normal hemoglobin (A) and one gene for sickle hemoglobin (S) from their parents. Because they have one (A) gene, individuals with traits do not have any medical problems, but they can pass the (S) gene to their children. </p><p><strong>People with sickle cell disease (SS) </strong><span style=\"color: rgb(230, 0, 0);\">inherit two genes for sickle hemoglobin (S) from their parents</span>. They have symptoms because their red blood cells do not make normal hemoglobin. </p><p><span style=\"color: rgb(230, 0, 0);\">sickle Trait=T</span> <span style=\"color: rgb(230, 0, 0);\">sickle Disease =D</span> T-one S gene D-double SS gene T-20-40% of hemoglobin is hemoglobin S D-80-100% is HBS T-do not have any health problem D-no symptoms under normal conditions But in sickling crisis such as infection and dehydration, they get symptoms plus anemia and jaundice.</p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">The diagnostic test-</strong></p><ul><li>The best initial test is a peripheral smear. Sickle cell trait (AS disease) does not give sickled cells. The most accurate test is hemoglobin electrophoresis.</li><li>Do not wait for the results of testing to start antibiotics if there is a fever. The absence of a functional spleen leads to overwhelming infection.</li><li>Patients with sickle cell disease usually have very high reticulocyte counts because of the chronic compensated hemolysis.</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">Treatment of Sickle cell disease</strong></p><p><a href=\"https://emedicine.medscape.com/article/205926-workup#c1\" target=\"_blank\">Sickle Cell Anemia Workup: Approach Considerations, Baseline Blood Study Abnormalities, Suggested Routine Clinical Laboratory Evaluations (medscape.com)</a></p><p>Treatment</p><ul><li>Begin with oxygen/hydration/analgesia. If fever or a white blood cell count higher than usual is present, then antibiotics are given. Use ceftriaxone, levofloxacin, or moxifloxacin.</li><li>Folic acid replacement is necessary on a chronic basis.</li><li>Give pneumococcal vaccination because of auto splenectomy.</li><li>Hydroxyurea prevents recurrences of sickle cell crises by increasing hemoglobin F. Increase the dose of hydroxyurea until the hemoglobin F level rises above 10–15%. If WBC is low, do not increase the dose.</li></ul><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">TIPS</strong></p><ul><li>Sickle cell is caused by a point mutation at position <span style=\"color: rgb(230, 0, 0);\">6 of the beta-globin chain:</span> Valine replaces glutamic acid.</li><li>Normal Adult Hemoglobin Electrophoresis showed -HBA 95-98%, HbA2-2-3% and HBF is less than 1-2%</li><li>Sickle cell Trait Hemoglobin electrophoresis(HBEP) showed-HBS 20-40 rest is HBA,HBA2 and HBS( Normally HBS is zero%)</li><li>Sickle cell disease HBEP-HBS 40-80% rest id HBA , HBA2 and HBF</li><li>Thalassemia Minor -HBEP has-HBA2 more than 5% rest is HBA and HBF(tey are asymptomatic, No treatment required), NO HBS</li><li>Thalassemia Major -HBEP has-HBF more than 90%, Rest is HBA and HBA2, NO HBS(diagnosed in childhood, RX is Lifelong blood transfusion and chelation with no cure. Bone marrow transplantation is the only curative treatment for Thalassemia Major</li></ul><p><br></p><h5><strong style=\"color: rgb(230, 0, 0);\">Sickle Cell Trait</strong><span style=\"color: rgb(230, 0, 0);\"> </span></h5><h5>Sickle cell trait means the patient is heterozygous for the sickle gene (AS). The only manifestation of the sickle cell trait is a defect in the ability to concentrate the urine or “isosthenuria.” They are clinically asymptomatic and have both a normal CBC level and a normal smear result. Hematuria may sometimes occur. There is no treatment for sickle cell trait.</h5>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Sickle cell trait<br/><p><span style=\"color: rgb(230, 0, 0);\">What is the difference between sickle cell disease and trait? </span></p><p><strong>People with sickle cell trait (AS) </strong>inherit one gene for normal hemoglobin (A) and one gene for sickle hemoglobin (S) from their parents. Because they have one (A) gene, individuals with traits do not have any medical problems, but they can pass the (S) gene to their children. </p><p><strong>People with sickle cell disease (SS) </strong><span style=\"color: rgb(230, 0, 0);\">inherit two genes for sickle hemoglobin (S) from their parents</span>. They have symptoms because their red blood cells do not make normal hemoglobin. </p><p><span style=\"color: rgb(230, 0, 0);\">sickle Trait=T</span> <span style=\"color: rgb(230, 0, 0);\">sickle Disease =D</span> T-one S gene D-double SS gene T-20-40% of hemoglobin is hemoglobin S D-80-100% is HBS T-do not have any health problem D-no symptoms under normal conditions But in sickling crisis such as infection and dehydration, they get symptoms plus anemia and jaundice.</p><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">The diagnostic test-</strong></p><ul><li>The best initial test is a peripheral smear. Sickle cell trait (AS disease) does not give sickled cells. The most accurate test is hemoglobin electrophoresis.</li><li>Do not wait for the results of testing to start antibiotics if there is a fever. The absence of a functional spleen leads to overwhelming infection.</li><li>Patients with sickle cell disease usually have very high reticulocyte counts because of the chronic compensated hemolysis.</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">Treatment of Sickle cell disease</strong></p><p><a href=\"https://emedicine.medscape.com/article/205926-workup#c1\" target=\"_blank\">Sickle Cell Anemia Workup: Approach Considerations, Baseline Blood Study Abnormalities, Suggested Routine Clinical Laboratory Evaluations (medscape.com)</a></p><p>Treatment</p><ul><li>Begin with oxygen/hydration/analgesia. If fever or a white blood cell count higher than usual is present, then antibiotics are given. Use ceftriaxone, levofloxacin, or moxifloxacin.</li><li>Folic acid replacement is necessary on a chronic basis.</li><li>Give pneumococcal vaccination because of auto splenectomy.</li><li>Hydroxyurea prevents recurrences of sickle cell crises by increasing hemoglobin F. Increase the dose of hydroxyurea until the hemoglobin F level rises above 10–15%. If WBC is low, do not increase the dose.</li></ul><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">TIPS</strong></p><ul><li>Sickle cell is caused by a point mutation at position <span style=\"color: rgb(230, 0, 0);\">6 of the beta-globin chain:</span> Valine replaces glutamic acid.</li><li>Normal Adult Hemoglobin Electrophoresis showed -HBA 95-98%, HbA2-2-3% and HBF is less than 1-2%</li><li>Sickle cell Trait Hemoglobin electrophoresis(HBEP) showed-HBS 20-40 rest is HBA,HBA2 and HBS( Normally HBS is zero%)</li><li>Sickle cell disease HBEP-HBS 40-80% rest id HBA , HBA2 and HBF</li><li>Thalassemia Minor -HBEP has-HBA2 more than 5% rest is HBA and HBF(tey are asymptomatic, No treatment required), NO HBS</li><li>Thalassemia Major -HBEP has-HBF more than 90%, Rest is HBA and HBA2, NO HBS(diagnosed in childhood, RX is Lifelong blood transfusion and chelation with no cure. Bone marrow transplantation is the only curative treatment for Thalassemia Major</li></ul><p><br></p><h5><strong style=\"color: rgb(230, 0, 0);\">Sickle Cell Trait</strong><span style=\"color: rgb(230, 0, 0);\"> </span></h5><h5>Sickle cell trait means the patient is heterozygous for the sickle gene (AS). The only manifestation of the sickle cell trait is a defect in the ability to concentrate the urine or “isosthenuria.” They are clinically asymptomatic and have both a normal CBC level and a normal smear result. Hematuria may sometimes occur. There is no treatment for sickle cell trait.</h5>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">12. In which of the following conditions is regular intravenous immunoglobulin (IVIg) replacement therapy an absolute indication?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. AIDS</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Chronic granulomatous disease</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. IgG2 subclass deficiency</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. SCID (severe combined immunodeficiency)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. None of the above</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : SCID (severe combined immunodeficiency)<br/>Severe combined immunodeficiency, SCID, is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells caused by numerous genetic mutations that result in differing clinical presentations.[2] SCID involves defective antibody response due to either direct involvement with B lymphocytes or through improper B lymphocyte activation due to non-functional T-helper cells.[3] Consequently, both \"arms\" (B cells and T cells) of the adaptive immune system are impaired due to a defect in one of several possible genes.<br />\n<br />\nThe most common treatment for SCID is bone marrow transplantation,<br />\n<br />\nTreatment of SCID<br />\n<br />\nReverse isolation <br />\n<br />\nAntibiotics, antifungal drugs, and immune globulin to prevent infections <br />\n<br />\nStem cell transplantation <br />\n<br />\nSometimes replacement of adenosine deaminase or gene therapy.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : SCID (severe combined immunodeficiency)<br/>Severe combined immunodeficiency, SCID, is a rare genetic disorder characterized by the disturbed development of functional T cells and B cells caused by numerous genetic mutations that result in differing clinical presentations.[2] SCID involves defective antibody response due to either direct involvement with B lymphocytes or through improper B lymphocyte activation due to non-functional T-helper cells.[3] Consequently, both \"arms\" (B cells and T cells) of the adaptive immune system are impaired due to a defect in one of several possible genes.<br />\n<br />\nThe most common treatment for SCID is bone marrow transplantation,<br />\n<br />\nTreatment of SCID<br />\n<br />\nReverse isolation <br />\n<br />\nAntibiotics, antifungal drugs, and immune globulin to prevent infections <br />\n<br />\nStem cell transplantation <br />\n<br />\nSometimes replacement of adenosine deaminase or gene therapy.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">13. Drug avoided in breast cancer chemotherapy patient with cardiac compromise or Low ejection fraction?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Mitoxantrone</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Paclitaxel</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Carboplatin</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Cyclophosphamide</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Mitoxantrone<br/>anthracyclin should be avoided like Mitoxantrone and doxorubicin.base line 2 D echo can be done in all patient prior to Anthracyclin chemotherapy for any indication..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Mitoxantrone<br/>anthracyclin should be avoided like Mitoxantrone and doxorubicin.base line 2 D echo can be done in all patient prior to Anthracyclin chemotherapy for any indication..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">14. A child with sickle cells disease treated in emergency. What is initial necessary precaution in the treatment?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Hydration</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Oxygen</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Prophylactic penicillin</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Hydroxyurea</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Hydration<br/>Sickle cell disease is a common genetic disorder characterised by periodic episodes of pain which usually happen again and again throughout life. These episodes occur when sickled cells obstruct blood vessels. The degree of pain may range from a mild discomfort to a severe disabling pain where the person needs treatment in hospital. A drop in body fluid levels promotes and sustains the sickling process. Routine treatment includes the use of drugs to relieve pain and the maintenance of adequate fluid levels. Fluid levels will fall if insufficient fluids are taken in compared to the amount of fluid lost. The kidneys of people with sickle cell disease do not concentrate urine properly, which results in poor control of bodily fluids. Additional fluids are given to try and slow or stop the sickling process which should reduce the amount and duration of pain. Fluids may be given in many ways, but orally or intravenously are most common. Fluids should be given with care so as to prevent fluid overload which may in turn cause adverse events such as heart failure or fluid building up in the lungs. We looked for randomised controlled trials to show the best way to replace fluids, which type of fluids and how much fluid to replace to treat acute episodes of pain in people with sickle cell disease..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Hydration<br/>Sickle cell disease is a common genetic disorder characterised by periodic episodes of pain which usually happen again and again throughout life. These episodes occur when sickled cells obstruct blood vessels. The degree of pain may range from a mild discomfort to a severe disabling pain where the person needs treatment in hospital. A drop in body fluid levels promotes and sustains the sickling process. Routine treatment includes the use of drugs to relieve pain and the maintenance of adequate fluid levels. Fluid levels will fall if insufficient fluids are taken in compared to the amount of fluid lost. The kidneys of people with sickle cell disease do not concentrate urine properly, which results in poor control of bodily fluids. Additional fluids are given to try and slow or stop the sickling process which should reduce the amount and duration of pain. Fluids may be given in many ways, but orally or intravenously are most common. Fluids should be given with care so as to prevent fluid overload which may in turn cause adverse events such as heart failure or fluid building up in the lungs. We looked for randomised controlled trials to show the best way to replace fluids, which type of fluids and how much fluid to replace to treat acute episodes of pain in people with sickle cell disease..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">15. Which of the following is a complication of B12 or folate replacement?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Seizures.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Hemolysis.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Hypokalemia.\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Hyperkalemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Diarrhea.</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Hypokalemia.\n<br/>Extremely rapid cell production in the bone marrow causes hypokalemia. There is no other condition in which cells are<br />\ngenerated so rapidly that they use up all the potassium. Hyperkalemia from massive tissue or cellular breakdown has many causes. Hypokalemia from cell production is rare. When replacing B12 and folate, particularly if there is pancytopenia, cells in the marrow are produced so rapidly that the marrow packages up all the potassium,lowering the serum level. Observe and replace..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Hypokalemia.\n<br/>Extremely rapid cell production in the bone marrow causes hypokalemia. There is no other condition in which cells are<br />\ngenerated so rapidly that they use up all the potassium. Hyperkalemia from massive tissue or cellular breakdown has many causes. Hypokalemia from cell production is rare. When replacing B12 and folate, particularly if there is pancytopenia, cells in the marrow are produced so rapidly that the marrow packages up all the potassium,lowering the serum level. Observe and replace..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">16. Tumorlysis syndrome have all except?</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/49516ac9c40b3ee4a54f69a1c2f48783.jpg"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Hyperkelemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Hyperuracemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Hyperphosphatemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Hypercalcemia</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : Hypercalcemia<br/>Tumor lysis syndrome is a group of metabolic abnormalities that can occur as a complication during the treatment of cancer,[1] where large amounts of tumor cells are killed off (lysed) at the same time by the treatment, releasing their contents into the bloodstream. This occurs most commonly after the treatment of lymphomas and leukemias. In oncology and hematology, this is a potentially fatal complication, and patients at increased risk for TLS should be closely monitored before, during, and after their course of chemotherapy. <br />\n<br />\nHyperkalemia. Potassium is mainly an intracellular ion. High turnover of tumor cells leads to spill of potassium into the blood. Symptoms usually do not manifest until levels are high (> 7 mmol/L) [normal 3.5–5.0 mmol/L] and they include <br />\ncardiac conduction abnormalities (can be fatal)<br />\nsevere muscle weakness or paralysis<br />\nHyperphosphatemia. Like potassium, phosphates are also predominantly intracellular. Hyperphosphatemia causes acute kidney failure in tumor lysis syndrome, because of deposition of calcium phosphate crystals in the kidney parenchyma.<br />\nHypocalcemia. Because of the hyperphosphatemia, calcium is precipitated to form calcium phosphate, leading to hypocalcemia. Symptoms of hypocalcemia include (but are not limited to): <br />\ntetany<br />\nsudden mental incapacity, including emotional lability<br />\nParkinsonian (extrapyramidal) movement disorders<br />\npapilledema<br />\nmyopathy<br />\nHyperuricemia[4] and hyperuricosuria. Massive cell death and nuclear breakdown generates large quantities of nucleic acids. Of these, the purines (adenine and guanine) are converted to uric acid via the purine degradation pathway and excreted in the urine. However, at the high concentrations of uric acid generated by tumor lysis, uric acid is apt to precipitate as monosodium urate crystals.<br />\nAcute uric acid nephropathy (AUAN) due to hyperuricosuria has been a dominant cause of acute kidney failure but with the advent of effective treatments for hyperuricosuria, AUAN has become a less common cause than hyperphosphatemia. Two common conditions related to excess uric acid, gout and uric acid nephrolithiasis, are not features of tumor lysis syndrome. <br />\nLactic acidosis.<br />\n<br />\n<a target=\"_blank\" href=\"https://en.wikipedia.org/wiki/Tumor_lysis_syndrome<br />\n\">https://en.wikipedia.org/wiki/Tumor_lysis_syndrome<br />\n</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : Hypercalcemia<br/>Tumor lysis syndrome is a group of metabolic abnormalities that can occur as a complication during the treatment of cancer,[1] where large amounts of tumor cells are killed off (lysed) at the same time by the treatment, releasing their contents into the bloodstream. This occurs most commonly after the treatment of lymphomas and leukemias. In oncology and hematology, this is a potentially fatal complication, and patients at increased risk for TLS should be closely monitored before, during, and after their course of chemotherapy. <br />\n<br />\nHyperkalemia. Potassium is mainly an intracellular ion. High turnover of tumor cells leads to spill of potassium into the blood. Symptoms usually do not manifest until levels are high (> 7 mmol/L) [normal 3.5–5.0 mmol/L] and they include <br />\ncardiac conduction abnormalities (can be fatal)<br />\nsevere muscle weakness or paralysis<br />\nHyperphosphatemia. Like potassium, phosphates are also predominantly intracellular. Hyperphosphatemia causes acute kidney failure in tumor lysis syndrome, because of deposition of calcium phosphate crystals in the kidney parenchyma.<br />\nHypocalcemia. Because of the hyperphosphatemia, calcium is precipitated to form calcium phosphate, leading to hypocalcemia. Symptoms of hypocalcemia include (but are not limited to): <br />\ntetany<br />\nsudden mental incapacity, including emotional lability<br />\nParkinsonian (extrapyramidal) movement disorders<br />\npapilledema<br />\nmyopathy<br />\nHyperuricemia[4] and hyperuricosuria. Massive cell death and nuclear breakdown generates large quantities of nucleic acids. Of these, the purines (adenine and guanine) are converted to uric acid via the purine degradation pathway and excreted in the urine. However, at the high concentrations of uric acid generated by tumor lysis, uric acid is apt to precipitate as monosodium urate crystals.<br />\nAcute uric acid nephropathy (AUAN) due to hyperuricosuria has been a dominant cause of acute kidney failure but with the advent of effective treatments for hyperuricosuria, AUAN has become a less common cause than hyperphosphatemia. Two common conditions related to excess uric acid, gout and uric acid nephrolithiasis, are not features of tumor lysis syndrome. <br />\nLactic acidosis.<br />\n<br />\n<a target=\"_blank\" href=\"https://en.wikipedia.org/wiki/Tumor_lysis_syndrome<br />\n\">https://en.wikipedia.org/wiki/Tumor_lysis_syndrome<br />\n</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">17. 60 years male,dysponea on exertion,no bleeding from any site, HB-6.5gm%,retic count-1%,B12 level 150(very low),MCV 120,diagnosed as megaloblastic anemia after full course of B12.his lab showed Hb 8,MCV 110.Liver and renal function test,LDh-normal,sonography is okay.what will be the next step for him?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Direct coomb’s test</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. ANA by IF</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Bone marrow biopsy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Iron profile</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Bone marrow biopsy<br/>Bone marrow biopsy...................... because this is elderly male with macrocytic anemia must rule out MDS(myelodysplastic syndrome) after b12 correction he has significant anemia means underlying second etiology is there so Bone marrow test is indicated as other parameters are normal like LFT,RFT and ultrasound so go for BM Biopsy.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Bone marrow biopsy<br/>Bone marrow biopsy...................... because this is elderly male with macrocytic anemia must rule out MDS(myelodysplastic syndrome) after b12 correction he has significant anemia means underlying second etiology is there so Bone marrow test is indicated as other parameters are normal like LFT,RFT and ultrasound so go for BM Biopsy.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">18. 20 years college girl,mildweakness,Hb 5gm%,skipping meals to be slim,diagnosed as severe iron deficiency anemia.you started oral iron which is very much intolerated to her what will you do?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Convince and counsel her to take on empty stomach</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Give blood transfusion</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. IV iron</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Will not give iron, only give B12 injection</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : IV iron<br/>Blood transfusion is avoided usually in young patient like this and minimal symptoms with iron deficiency.give IV iron first as patient is intolerant to oral iron.now Newer preparation like -FericCarboxy Maltose compound, only 15 minute day care infusion,no test dose and No anaphylaxismsafe overall.so IV iron best option for this patient and no risk of HIV,HBSAg and transfusion related infection like blood transfusion.<br />\n<br />\n<a target=\"_blank\" href=\"https://www.sahealth.sa.gov.au/wps/wcm/connect/a1b9b8804f25ca8fb5defd080fa6802e/FINAL+update+2+July+2015+with+tracked+changes+accepted_Intravenous+Iron+Infusion.pdf?MOD=AJPERES&CACHEID=a1b9b8804f25ca8fb5defd080fa6802e\">https://www.sahealth.sa.gov.au/wps/wcm/connect/a1b9b8804f25ca8fb5defd080fa6802e/FINAL+update+2+July+2015+with+tracked+changes+accepted_Intravenous+Iron+Infusion.pdf?MOD=AJPERES&CACHEID=a1b9b8804f25ca8fb5defd080fa6802e</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : IV iron<br/>Blood transfusion is avoided usually in young patient like this and minimal symptoms with iron deficiency.give IV iron first as patient is intolerant to oral iron.now Newer preparation like -FericCarboxy Maltose compound, only 15 minute day care infusion,no test dose and No anaphylaxismsafe overall.so IV iron best option for this patient and no risk of HIV,HBSAg and transfusion related infection like blood transfusion.<br />\n<br />\n<a target=\"_blank\" href=\"https://www.sahealth.sa.gov.au/wps/wcm/connect/a1b9b8804f25ca8fb5defd080fa6802e/FINAL+update+2+July+2015+with+tracked+changes+accepted_Intravenous+Iron+Infusion.pdf?MOD=AJPERES&CACHEID=a1b9b8804f25ca8fb5defd080fa6802e\">https://www.sahealth.sa.gov.au/wps/wcm/connect/a1b9b8804f25ca8fb5defd080fa6802e/FINAL+update+2+July+2015+with+tracked+changes+accepted_Intravenous+Iron+Infusion.pdf?MOD=AJPERES&CACHEID=a1b9b8804f25ca8fb5defd080fa6802e</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">19. High CA 125 is diagnostic of?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Ovarian cancer</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Breast cancer</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Endometrial cancer</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Fibroid</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. All of tha above</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">F. None of the above</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is F : None of the above<br/>High CA 125 helps in prognosis and suspion for diagnostic workup.....high CA 125 doesnt mean its ovarian cancer and normal CA 125 doesnot means that there is no cancers.<br />\nA CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in your blood.<br />\nA CA 125 test may be used to monitor certain cancers during and after treatment. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in women with a very high risk of the disease.<br />\nA CA 125 test isn't accurate enough to use for ovarian cancer screening in all women because many noncancerous conditions can increase the CA 125 level.<br />\nMany different conditions can cause an increase in CA 125, including normal conditions, such as menstruation, and noncancerous conditions, such as uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal and fallopian tube cancers..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is F : None of the above<br/>High CA 125 helps in prognosis and suspion for diagnostic workup.....high CA 125 doesnt mean its ovarian cancer and normal CA 125 doesnot means that there is no cancers.<br />\nA CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in your blood.<br />\nA CA 125 test may be used to monitor certain cancers during and after treatment. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in women with a very high risk of the disease.<br />\nA CA 125 test isn't accurate enough to use for ovarian cancer screening in all women because many noncancerous conditions can increase the CA 125 level.<br />\nMany different conditions can cause an increase in CA 125, including normal conditions, such as menstruation, and noncancerous conditions, such as uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal and fallopian tube cancers..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">20. FOLFOX chemotherapy is commonly used for?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Gastric carcinoma</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Colorectal cancer</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Breast cancer</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Lung cancer</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Ovarian cancer</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Colorectal cancer<br/>What FOLFOX is<br />\nFOLFOX is the name of a combination chemotherapy treatment. It is also known as Oxaliplatin de Gramont or OxMdG, which means Oxaliplatin modified de Gramont. It is made up of the drugs<br />\n- FOL – Folinic acid (also called leucovorin, FA or calcium folinate)<br />\n- F – Fluorouracil (5FU)<br />\n- OX – Oxaliplatin<br />\n- Oxaliplatin with fluorouracil (5FU) and folinic acid chemotherapy is a treatment which is usually used to treat bowel cancer. This combination of drugs may also be used to treat other types of cancer..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Colorectal cancer<br/>What FOLFOX is<br />\nFOLFOX is the name of a combination chemotherapy treatment. It is also known as Oxaliplatin de Gramont or OxMdG, which means Oxaliplatin modified de Gramont. It is made up of the drugs<br />\n- FOL – Folinic acid (also called leucovorin, FA or calcium folinate)<br />\n- F – Fluorouracil (5FU)<br />\n- OX – Oxaliplatin<br />\n- Oxaliplatin with fluorouracil (5FU) and folinic acid chemotherapy is a treatment which is usually used to treat bowel cancer. This combination of drugs may also be used to treat other types of cancer..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">21. Which of the following can be found on smear in sickle cell disease?</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/d44b7cc010973d783e3d5aa0f5240cbf.png"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Basophilic stippling.\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Howell-Jolly bodies </p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Bite cells</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Schistocytes.\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Morulae</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Howell-Jolly bodies <br/><p><strong style=\"color: rgb(230, 0, 0);\">These are precipitated remnants of nuclear material seen inside the red blood cells of a patient who does not have a spleen</strong>. There is no change in therapy or management based on the presence of Howell-Jolly bodies. Basophilic stippling is associated with a number of causes of sideroblastic anemia, especially lead poisoning. Bite cells are seen in glucose 6 phosphate dehydrogenase deficiency. Schistocytes are fragmented red blood cells seen with intravascular hemolysis. Morulae are seen inside neutrophils in Ehrlichia infections. TIPS What lowers mortality in sickle cell disease? -Hydroxyurea in prevention -Antibiotics with fever.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Howell-Jolly bodies <br/><p><strong style=\"color: rgb(230, 0, 0);\">These are precipitated remnants of nuclear material seen inside the red blood cells of a patient who does not have a spleen</strong>. There is no change in therapy or management based on the presence of Howell-Jolly bodies. Basophilic stippling is associated with a number of causes of sideroblastic anemia, especially lead poisoning. Bite cells are seen in glucose 6 phosphate dehydrogenase deficiency. Schistocytes are fragmented red blood cells seen with intravascular hemolysis. Morulae are seen inside neutrophils in Ehrlichia infections. TIPS What lowers mortality in sickle cell disease? -Hydroxyurea in prevention -Antibiotics with fever.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">22. Usually Not seen in ITP (Immune Thrombocytopenic Purpura) except?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Splenomegaly</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. ANA positive</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Usually increase megakaryocytes in bone marrow</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. DCT positive</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Usually increase megakaryocytes in bone marrow<br/>Dear doctors read questions again here asked except...means A,B ad D is NOT seen--except means seen and thats increase megakaryocytes...........Splenomegaly never or rarely present is ITP..ITP is a diagnosis of exclusion ,means examination completely normal except signs of bleeding or petechie due to low platelet,,no lymphadenopathy or no hepatosplenomegaly with normal examination of bone marrow wxcept increase number of megakaryocytes<br />\n<br />\nClinical Pearl <br />\nPlatelet disorders can broadly be classified into 2 groups: <br />\n•  Quantitative (low platelet count, eg, ITP) <br />\n•  Qualitative (normal platelet count but abnormal platelet function, eg, Von Willebrand, Bernard Soulier).</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Usually increase megakaryocytes in bone marrow<br/>Dear doctors read questions again here asked except...means A,B ad D is NOT seen--except means seen and thats increase megakaryocytes...........Splenomegaly never or rarely present is ITP..ITP is a diagnosis of exclusion ,means examination completely normal except signs of bleeding or petechie due to low platelet,,no lymphadenopathy or no hepatosplenomegaly with normal examination of bone marrow wxcept increase number of megakaryocytes<br />\n<br />\nClinical Pearl <br />\nPlatelet disorders can broadly be classified into 2 groups: <br />\n•  Quantitative (low platelet count, eg, ITP) <br />\n•  Qualitative (normal platelet count but abnormal platelet function, eg, Von Willebrand, Bernard Soulier).</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">23. Following genetic counselling in a family for Familial polyposis coli (FPC) next screening test is</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Flexible sigmoidoscopy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Colonoscopy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Occult blood in stools</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. APC gene</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : APC gene<br/>APC gene<br />\nClassic familial adenomatous polyposis, called FAP or classic FAP, is a genetic condition. It is diagnosed when a person develops more than 100 adenomatous colon polyps. An adenomatous polyp is an area where normal cells that line the inside of a person’s colon form a mass on the inside of the intestinal tract. The average age for polyps to develop in people with FAP is in the mid-teens. More than 95% of people with FAP will have multiple colon polyps by age 35. If FAP is not recognized and treated, there is almost a 100% chance that a person will develop colorectal cancer<br />\nWhat causes classic FAP?<br />\nFAP is passed from generation to generation in a family. The APC gene is linked to FAP; APC stands foradenomatous polyposis coli. A mutation (alteration) in the APC gene gives a person an increased lifetime risk of developing colorectal cancer or other cancers of the digestive tract. <br />\nhttp://www.cancer.net/cancer-types/familial-adenomatous-polyposis.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : APC gene<br/>APC gene<br />\nClassic familial adenomatous polyposis, called FAP or classic FAP, is a genetic condition. It is diagnosed when a person develops more than 100 adenomatous colon polyps. An adenomatous polyp is an area where normal cells that line the inside of a person’s colon form a mass on the inside of the intestinal tract. The average age for polyps to develop in people with FAP is in the mid-teens. More than 95% of people with FAP will have multiple colon polyps by age 35. If FAP is not recognized and treated, there is almost a 100% chance that a person will develop colorectal cancer<br />\nWhat causes classic FAP?<br />\nFAP is passed from generation to generation in a family. The APC gene is linked to FAP; APC stands foradenomatous polyposis coli. A mutation (alteration) in the APC gene gives a person an increased lifetime risk of developing colorectal cancer or other cancers of the digestive tract. <br />\nhttp://www.cancer.net/cancer-types/familial-adenomatous-polyposis.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">24. Cold aglutin disease all true exept?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Cold agglutinin are IgM antibodies againt red blood cells</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Associated with EBV, Waldenstrommacroglobinemia or Mycoplasma pneumonia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Cold agglutinin titer is most accurate test</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Prednisolone is drug of choice</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. All of above correct</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : Prednisolone is drug of choice<br/>steroid and splenectomydonot works in cold agglutinin disease..prednisolone is most common wrong answer .MTB…page 216.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : Prednisolone is drug of choice<br/>steroid and splenectomydonot works in cold agglutinin disease..prednisolone is most common wrong answer .MTB…page 216.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">25. G6 PD deficiency is a X linked recessive disorder.leading to inability to generate glutathione reductase and protect red blood cells from oxidant stress.the most common oxidant stress is?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Infection</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Dapsone</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Sulpha drugs</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Fava beans</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Infection<br/>MTB page 235 G6 PD.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Infection<br/>MTB page 235 G6 PD.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">26. G6 PD deficiency, best initial test is Heinz bodies and Bite cells.G6PD level is normal after acute hemolystic event.in case of haemolytic event in G6PD deficient person what is the recommended or best time to repeat G6PD level?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. After 24 hours</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. After 1 week</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. After 2 weeks</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. After 1-2 months</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : After 1-2 months<br/>D -Glucose 6 Phosphate Dehydrogenase Deficiency<br />\n Etiology Glucose 6 phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive disorder leading to an inability to generate glutathione reductase and protect the red cells from oxidant stress. The most common oxidant stress is infection. Other causes are dapsone, quinidine, sulfa drugs, primaquine, nitrofurantoin, and fava beans.<br />\n<br />\n “What Is the Most Likely Diagnosis?” Look for African American or Mediterranean men with sudden anemia and jaundice who have a normal-sized spleen with an infection or are using one of the drugs previously listed.<br />\nBecause G6PD deficiency is X-linked recessive, it manifests almost exclusively in men.<br />\n<br />\nDiagnostic Tests<br />\nHeinz bodies are seen on special stain (methylene blue).<br />\nThe best initial test is for Heinz bodies and bite cells. The G6PD level will be normal after a<br />\n<br />\nhemolytic event. The most accurate test is the G6PD level after waiting 1 to 2 months after an acute episode of hemolysis.<br />\nTreatment Nothing reverses the hemolysis. Avoid oxidant stress..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : After 1-2 months<br/>D -Glucose 6 Phosphate Dehydrogenase Deficiency<br />\n Etiology Glucose 6 phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive disorder leading to an inability to generate glutathione reductase and protect the red cells from oxidant stress. The most common oxidant stress is infection. Other causes are dapsone, quinidine, sulfa drugs, primaquine, nitrofurantoin, and fava beans.<br />\n<br />\n “What Is the Most Likely Diagnosis?” Look for African American or Mediterranean men with sudden anemia and jaundice who have a normal-sized spleen with an infection or are using one of the drugs previously listed.<br />\nBecause G6PD deficiency is X-linked recessive, it manifests almost exclusively in men.<br />\n<br />\nDiagnostic Tests<br />\nHeinz bodies are seen on special stain (methylene blue).<br />\nThe best initial test is for Heinz bodies and bite cells. The G6PD level will be normal after a<br />\n<br />\nhemolytic event. The most accurate test is the G6PD level after waiting 1 to 2 months after an acute episode of hemolysis.<br />\nTreatment Nothing reverses the hemolysis. Avoid oxidant stress..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">27. Child on chemotherapy, he developed septicaemia after introduce IV cannula, what is causative organisms?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Hib virus</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Pseudomonas</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. E.coli</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Streptococcus</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Klebsiella</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Pseudomonas<br/>B most common IV line introduce infection.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Pseudomonas<br/>B most common IV line introduce infection.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">28. 50 year male with positive occult blood stool and family history of colon cancer.The best screening test for colon cancer is</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. MRI</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. CT SCAN</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Colonoscopy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Ultrasound</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Colonoscopy<br/>The U.S. Preventive Services Task Force recommends<br />\nExternal<br />\n<br />\nthat adults age 50 to 75 be screened for colorectal cancer. The decision to be screened after age 75 should be made on an individual basis. If you are older than 75, ask your doctor if you should be screened. People at an increased risk of getting colorectal cancer should talk to their doctor about when to begin screening, which test is right for them, and how often to get tested.<br />\nColonoscopy<br />\nThis is similar to flexible sigmoidoscopy, except the doctor uses a longer, thin, flexible, lighted tube to check for polyps or cancer inside the rectum and the entire colon. During the test, the doctor can find and remove most polyps and some cancers. Colonoscopy also is used as a follow-up test if anything unusual is found during one of the other screening tests.<br />\nHow often: Every 10 years (for people who do not have an increased risk of colorectal cancer).<br />\n<br />\n<br><a target=\"_blank\" href=\"https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/screening-tests-used.html\">https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/screening-tests-used.html</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Colonoscopy<br/>The U.S. Preventive Services Task Force recommends<br />\nExternal<br />\n<br />\nthat adults age 50 to 75 be screened for colorectal cancer. The decision to be screened after age 75 should be made on an individual basis. If you are older than 75, ask your doctor if you should be screened. People at an increased risk of getting colorectal cancer should talk to their doctor about when to begin screening, which test is right for them, and how often to get tested.<br />\nColonoscopy<br />\nThis is similar to flexible sigmoidoscopy, except the doctor uses a longer, thin, flexible, lighted tube to check for polyps or cancer inside the rectum and the entire colon. During the test, the doctor can find and remove most polyps and some cancers. Colonoscopy also is used as a follow-up test if anything unusual is found during one of the other screening tests.<br />\nHow often: Every 10 years (for people who do not have an increased risk of colorectal cancer).<br />\n<br />\n<br><a target=\"_blank\" href=\"https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/screening-tests-used.html\">https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/screening-tests-used.html</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">29. In general, which of the following is the greatest risk factor for the development of cancer?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Age</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Alcohol use</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Cigarette smoking</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Female sex</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Obesity</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Age<br/>Although cigarette smoking is the greatest modifiable risk factor for the development of cancer, the most significant risk factor for cancer in general is age. Two-thirds of all cancers are diagnosed in individuals older than 65 years, and the risk of developing cancer between the ages of 60 and 79 years is one in three in men and one in five in women. In contrast, the risk of cancer between birth and age 49 years is one in 70 for boys and men and one in 48 for girls and women. Overall, men have a slightly greater risk of developing cancer than women (44% vs. 38% lifetime risk)..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Age<br/>Although cigarette smoking is the greatest modifiable risk factor for the development of cancer, the most significant risk factor for cancer in general is age. Two-thirds of all cancers are diagnosed in individuals older than 65 years, and the risk of developing cancer between the ages of 60 and 79 years is one in three in men and one in five in women. In contrast, the risk of cancer between birth and age 49 years is one in 70 for boys and men and one in 48 for girls and women. Overall, men have a slightly greater risk of developing cancer than women (44% vs. 38% lifetime risk)..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">30. Breast cancer poor prognosis factors are all except</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Estrogen receptor positive</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Her 2 status positive</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Stage / grade-advance</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Lymph node status-positive</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Size-T3</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Estrogen receptor positive<br/>A ER positive is good prognosis<br />\nAll cases of invasive breast carcinoma are evaluated for ER/PR status using immunohistochemistry, which has both predictive and prognostic value. The presence of hormone receptors is a powerful predictive factor for the likelihood of benefit from adjuvant hormonal therapy including aromatase inhibitors (e.g., anastrozole, letrozole) and tamoxifen, an oral selective estrogen receptor modulator.13-15 As a prognostic factor, ER and/or PR positivity is associated with reduced mortality compared to women with ER and/or PR negative disease.16 However, the percentage of immunohistochemically positive tumor cells used to classify a tumor as ER or PR positive varies among institutions. Studies support that carcinomas with >1% ER positive cells have better survival rates compared to carcinomas that are completely devoid of ER.<br />\n<br><a target=\"_blank\" href=\"http://www.cap.org/apps/docs/newspath/0709/prognostic_and_predictive_factors_in_breast_cancer.pdf\">http://www.cap.org/apps/docs/newspath/0709/prognostic_and_predictive_factors_in_breast_cancer.pdf</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Estrogen receptor positive<br/>A ER positive is good prognosis<br />\nAll cases of invasive breast carcinoma are evaluated for ER/PR status using immunohistochemistry, which has both predictive and prognostic value. The presence of hormone receptors is a powerful predictive factor for the likelihood of benefit from adjuvant hormonal therapy including aromatase inhibitors (e.g., anastrozole, letrozole) and tamoxifen, an oral selective estrogen receptor modulator.13-15 As a prognostic factor, ER and/or PR positivity is associated with reduced mortality compared to women with ER and/or PR negative disease.16 However, the percentage of immunohistochemically positive tumor cells used to classify a tumor as ER or PR positive varies among institutions. Studies support that carcinomas with >1% ER positive cells have better survival rates compared to carcinomas that are completely devoid of ER.<br />\n<br><a target=\"_blank\" href=\"http://www.cap.org/apps/docs/newspath/0709/prognostic_and_predictive_factors_in_breast_cancer.pdf\">http://www.cap.org/apps/docs/newspath/0709/prognostic_and_predictive_factors_in_breast_cancer.pdf</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">31. Which of the following Hodgkin's Lymphoma histology has best prognosis?<br />\nClick below picture to enlarge view of Reed Sternberg cell</p>"
          },
          "image": [
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/c6831b4652a0b53af05602b7fe076e7a.jpg"
            },
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/fd0dd0343391d0fd6a1cbf039a5a68fd.jpg"
            }
          ],
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Nodular sclerosis</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Mixed cellularity</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Lymphocyte predominance</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Lymphocyte depleted</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Lymphocyte predominance<br/><p>HL=Hodgkin's Lymphoma, NHL is Non-Hodgkin's Lymphoma</p><p><br></p><p>B symptoms mean the presence of Fever, Night sweat or weight loss- presence of B symptoms carries a bad prognosis</p><p>HL histology</p><p>1- Nodular sclerosis-Most common</p><p>2-Lymphocyte Predominance-Best Prognosis</p><p>3-Lymphocyte depleted-Worst Prognosis</p><p><br></p><p>Diagnosis of HL and NHL</p><p>Excisional Lymph node biopsy</p><p><br></p><p>Staging of HL and NHL by</p><p>CT scan or PET CT scan</p><p>Treatment</p><p>HL-ABVD chemotherapy</p><p>NHL-R CHOP chemotherapy</p><p><br></p><p>Refractory or relapse cases -Stem cell transplant or Bone marrow transplant</p><p><br></p><p>HL </p><ul><li>Local, stage I, and stage II in 80%– 90%</li><li>Centers around the cervical area</li><li>Reed-Sternberg cells on pathology</li><li>Pathologic classification: Lymphocyte predominant has the best prognosis. Lymphocyte depleted has the worst prognosis.</li></ul><p>NHL</p><ul><li>Stage III and stage IV in 80%–90%&nbsp;</li><li>Disseminated&nbsp;</li><li>No Reed-Sternberg cells&nbsp;</li><li>Pathologic classification: Burkitt and immunoblastic have the worst prognosis.&nbsp;</li></ul><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">Adverse Effects of Chemotherapy </strong></p><p>Chemotherapeutic agent Toxicity </p><p>Doxorubicin -Cardiomyopathy </p><p>Vincristine -Neuropathy </p><p>Bleomycin -Lung fibrosis </p><p>Cyclophosphamide -Hemorrhagic cystitis </p><p>Cisplatin -Renal toxicity, ototoxicity, neurotoxicity&nbsp;</p><p><br></p><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Lymphocyte predominance<br/><p>HL=Hodgkin's Lymphoma, NHL is Non-Hodgkin's Lymphoma</p><p><br></p><p>B symptoms mean the presence of Fever, Night sweat or weight loss- presence of B symptoms carries a bad prognosis</p><p>HL histology</p><p>1- Nodular sclerosis-Most common</p><p>2-Lymphocyte Predominance-Best Prognosis</p><p>3-Lymphocyte depleted-Worst Prognosis</p><p><br></p><p>Diagnosis of HL and NHL</p><p>Excisional Lymph node biopsy</p><p><br></p><p>Staging of HL and NHL by</p><p>CT scan or PET CT scan</p><p>Treatment</p><p>HL-ABVD chemotherapy</p><p>NHL-R CHOP chemotherapy</p><p><br></p><p>Refractory or relapse cases -Stem cell transplant or Bone marrow transplant</p><p><br></p><p>HL </p><ul><li>Local, stage I, and stage II in 80%– 90%</li><li>Centers around the cervical area</li><li>Reed-Sternberg cells on pathology</li><li>Pathologic classification: Lymphocyte predominant has the best prognosis. Lymphocyte depleted has the worst prognosis.</li></ul><p>NHL</p><ul><li>Stage III and stage IV in 80%–90%&nbsp;</li><li>Disseminated&nbsp;</li><li>No Reed-Sternberg cells&nbsp;</li><li>Pathologic classification: Burkitt and immunoblastic have the worst prognosis.&nbsp;</li></ul><p><br></p><p><strong style=\"color: rgb(230, 0, 0);\">Adverse Effects of Chemotherapy </strong></p><p>Chemotherapeutic agent Toxicity </p><p>Doxorubicin -Cardiomyopathy </p><p>Vincristine -Neuropathy </p><p>Bleomycin -Lung fibrosis </p><p>Cyclophosphamide -Hemorrhagic cystitis </p><p>Cisplatin -Renal toxicity, ototoxicity, neurotoxicity&nbsp;</p><p><br></p><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">32. Anemia with low MCV and low retic count usually all except?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Iron deficiency anemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Anemia of chronic disease</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Alpha thalseemia with three gene deleted</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. None of above</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Alpha thalseemia with three gene deleted<br/>Alpha thalassemia with 3 gene deletion is the only anemia has low MCV with High reticcount,usually low MCV anemia has low retic count .most low MCV anemia has production problem<br />\nRef-MTB page 223.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Alpha thalseemia with three gene deleted<br/>Alpha thalassemia with 3 gene deletion is the only anemia has low MCV with High reticcount,usually low MCV anemia has low retic count .most low MCV anemia has production problem<br />\nRef-MTB page 223.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">33. Patient with long history of Ulcerative colitis, on endoscopy, you see polyp and cancer lesion on left colon.what would be most appropriate treatment?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Treatment of anemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Total colectomy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Left hemicolectomy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Remove polyp</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Total colectomy<br/>Like FAP, hereditary nonpolyposis colorectal cancer (HNPCC) is an inherited colorectal cancer syndrome. Although patients with HNPCC do not develop as large a number of polyps as those with FAP do, they have an 80% lifetime incidence of colorectal cancer.Surgical resection of the entire colon is the only definitive way of preventing colon cancer. Thus, patients with HNPCC may choose to undergo prophylactic total colectomy or proctocolectomy.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Total colectomy<br/>Like FAP, hereditary nonpolyposis colorectal cancer (HNPCC) is an inherited colorectal cancer syndrome. Although patients with HNPCC do not develop as large a number of polyps as those with FAP do, they have an 80% lifetime incidence of colorectal cancer.Surgical resection of the entire colon is the only definitive way of preventing colon cancer. Thus, patients with HNPCC may choose to undergo prophylactic total colectomy or proctocolectomy.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">34. A 15year girl was admitted with anemia, chest infection and thrombocytopenia. She was treated for the same and her symptoms had regressed. She was brought again with fever and the same symptoms afew days later. She also seems to have features of meningitis. What is the most likely diagnosis is?</p>"
          },
          "image": [
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/0ed4bc6b118070b01ce075cbb379761e.jpg"
            },
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/6a61654f1894eac1f157a2bfb1188f9a.png"
            }
          ],
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. AML (Acute Myeloid Leukemia)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. ALL (Acute Lymphoblastic Leukemia)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Aplastic anemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. CML (Chronic Myeloid Leukemia)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. CLL (Chronic Lymphoblastic Leukemia)</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : ALL (Acute Lymphoblastic Leukemia)<br/><p>ALL-age, cytopenias, meningitis --most likely Acute Lymphoblastic leukemia as compared to myeloid Leukemia.</p><p>lymphoid spreads to the spine, meninges and testis in male........in ALL that's why given CNS prophylaxis given to all patient in terms of RT to brain /triple chemo intrathecally that cytarabine, steroid and methotrexate.</p><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : ALL (Acute Lymphoblastic Leukemia)<br/><p>ALL-age, cytopenias, meningitis --most likely Acute Lymphoblastic leukemia as compared to myeloid Leukemia.</p><p>lymphoid spreads to the spine, meninges and testis in male........in ALL that's why given CNS prophylaxis given to all patient in terms of RT to brain /triple chemo intrathecally that cytarabine, steroid and methotrexate.</p><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">35. A 43-year-old man with sickle cell disease is admitted with an acute pain crisis. His only routine medication is folic acid. His<br />\nhematocrit on admission is 34%. On the third hospital day, the hematocrit drops to 22%.What is the best initial test?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Reticulocyte count.\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Peripheral smear.\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Folate level.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Parvovirus B-19 IgM level.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Bone marrow.\n</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Reticulocyte count.\n<br/>Patients with sickle cell disease usually have very high reticulocyte counts because of the chronic compensated hemolysis.<br />\nParvovirus B-19 causes an aplastic crisis which freezes the growth of the marrow. Nothing will be visible on blood smear. Although the bone marrow will show giant pronormoblasts, this would not be done routinely, and certainly never as the initial test. The first clue to parvovirus is a sudden drop in reticulocyte level.<br />\nTIPS<br />\n-The most accurate test for parvovirus B-19 is a PCR for DNA.<br />\n-This is more accurate than the IgM level. Intravenous immunoglobulin is the best initial therapy..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Reticulocyte count.\n<br/>Patients with sickle cell disease usually have very high reticulocyte counts because of the chronic compensated hemolysis.<br />\nParvovirus B-19 causes an aplastic crisis which freezes the growth of the marrow. Nothing will be visible on blood smear. Although the bone marrow will show giant pronormoblasts, this would not be done routinely, and certainly never as the initial test. The first clue to parvovirus is a sudden drop in reticulocyte level.<br />\nTIPS<br />\n-The most accurate test for parvovirus B-19 is a PCR for DNA.<br />\n-This is more accurate than the IgM level. Intravenous immunoglobulin is the best initial therapy..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">36. 34 years female with HIV,PAP smear negative, about cervical cancer screning:</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. After 3Month if negative repeat after 6months</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. After 6 Months if negative repeat annually</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. After 1year if negative repeat annually</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : After 6 Months if negative repeat annually.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : After 6 Months if negative repeat annually.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">37. A patient presents with increased bilirubin, LDH, and reticulocyte count and decreased platelet count of 30,000.<br />\nCreatinine level is elevated, and smear is positive for schistocytes. There is no history of diarrhea. <br />\nWhat is the next step in management?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Steroids</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Eculizumab</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Platelets</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. IVIG(IV immunoglobulins)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Ciprofloxacin</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">F. Supplementation with vitamins C and D</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Eculizumab<br/>This patient has hemolytic uremic syndrome (HUS).Eculizumab removes complement C5 and interrupts the hemolysis of<br />\nHUS. Steroids help TTP because antibodies attack ADAMTS13.Platelets worsen both HUS and TTP. IVIG is useless (although<br />\nplasma exchange helps). Antibiotics can worsen HUS..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Eculizumab<br/>This patient has hemolytic uremic syndrome (HUS).Eculizumab removes complement C5 and interrupts the hemolysis of<br />\nHUS. Steroids help TTP because antibodies attack ADAMTS13.Platelets worsen both HUS and TTP. IVIG is useless (although<br />\nplasma exchange helps). Antibiotics can worsen HUS..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">38. Alkalinization of urine is done during administration of which of the following chemotherapeutic drugs?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Ara-C (Cytarabine)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Methotrexate</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Cisplatin</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Ifosfamide</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Methotrexate<br/>Methotrexate. Alkalinization of urine is used in patients receiving high dose methotrexate to promote renal excretion and to avoid nephrotoxicity<br />\nIV Sodium bicarbonate is used to maintain urine pH above 7.0 to avoid precipitation of methotrexate (a weak acid) in the acid pH of renal tubules.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Methotrexate<br/>Methotrexate. Alkalinization of urine is used in patients receiving high dose methotrexate to promote renal excretion and to avoid nephrotoxicity<br />\nIV Sodium bicarbonate is used to maintain urine pH above 7.0 to avoid precipitation of methotrexate (a weak acid) in the acid pH of renal tubules.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">39. Cervical cancer vaccine active against all except?<br />\nclick below image to enlarge view</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/83eff80bca8f353c718c584b1405711d.png"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. HPV 6, 11</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. HPV 16, 18</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. HPV 23, 24</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. None of above</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : HPV 23, 24<br/>Gardasil, the new vaccine against human papilloma virus (HPV) –HPV, which causes cervical cancer and genital warts <br />\nHere is what you need to know now about this new vaccine.<br />\n1. What is Gardasil?<br />\nGardasil is a vaccine, licensed for use in June 2006, by the FDA. It targets four strains of human papillomavirus (HPV) -- HPV-6, 11, 16, and 18. HPV-16 and HPV-18 account for about 70% of all cervical cancers. HPV-6 and -11 cause about 90% of genital warts. HPV is also linked to anal cancer..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : HPV 23, 24<br/>Gardasil, the new vaccine against human papilloma virus (HPV) –HPV, which causes cervical cancer and genital warts <br />\nHere is what you need to know now about this new vaccine.<br />\n1. What is Gardasil?<br />\nGardasil is a vaccine, licensed for use in June 2006, by the FDA. It targets four strains of human papillomavirus (HPV) -- HPV-6, 11, 16, and 18. HPV-16 and HPV-18 account for about 70% of all cervical cancers. HPV-6 and -11 cause about 90% of genital warts. HPV is also linked to anal cancer..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">40. 55 year lady has history of breast cancer.She underwent for operation before several months. Now she has bone pain and diagnosed as osteoporosis.Which is the most appropriate treatment?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Bisphosphonate</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Vit D supplement</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Regular exercise</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. None of the Above</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Bisphosphonate<br/><p><span style=\"color: rgb(230, 0, 0);\">Bisphosphonates are a class of drugs that prevent the loss of bone density, used to treat osteoporosis and similar disease</span>s. They are the most commonly prescribed drugs used to treat osteoporosis. They are called bisphosphonates because they have two phosphonates (PO(OH)2) groups. Evidence shows that they reduce the risk of fracture in postmenopausal women with osteoporosis. Bone tissue undergoes constant remodelling and is kept in balance (homeostasis) by osteoblasts creating bone and osteoclasts destroying bone. The uses of bisphosphonates include the prevention and treatment of osteoporosis, P<span style=\"color: rgb(230, 0, 0);\">aget's disease of bone, bone metastasis (with or without hypercalcemia), multiple myeloma, primary hyperparathyroidism, osteogenesis imperfecta, fibrous dysplasia,</span> and other conditions that exhibit bone fragility.</p><p><strong style=\"color: rgb(230, 0, 0);\">Monitor EGFR</strong> for bisphosphonate, Dose adjustment is needed in altered renal function patient</p><p>Long term administration can rarely cause <strong style=\"color: rgb(230, 0, 0);\">Osteonecrosis of the jaw</strong></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Bisphosphonate<br/><p><span style=\"color: rgb(230, 0, 0);\">Bisphosphonates are a class of drugs that prevent the loss of bone density, used to treat osteoporosis and similar disease</span>s. They are the most commonly prescribed drugs used to treat osteoporosis. They are called bisphosphonates because they have two phosphonates (PO(OH)2) groups. Evidence shows that they reduce the risk of fracture in postmenopausal women with osteoporosis. Bone tissue undergoes constant remodelling and is kept in balance (homeostasis) by osteoblasts creating bone and osteoclasts destroying bone. The uses of bisphosphonates include the prevention and treatment of osteoporosis, P<span style=\"color: rgb(230, 0, 0);\">aget's disease of bone, bone metastasis (with or without hypercalcemia), multiple myeloma, primary hyperparathyroidism, osteogenesis imperfecta, fibrous dysplasia,</span> and other conditions that exhibit bone fragility.</p><p><strong style=\"color: rgb(230, 0, 0);\">Monitor EGFR</strong> for bisphosphonate, Dose adjustment is needed in altered renal function patient</p><p>Long term administration can rarely cause <strong style=\"color: rgb(230, 0, 0);\">Osteonecrosis of the jaw</strong></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">41. A 19-year-old woman noticed a mass in her left breast 2 weeks ago while doing monthly breast self-examination. Her mother died of metastaticbreast cancer at the age of 40 years. Examination shows large dense breasts; a 2-cm, firm, mobile mass is palpated in the upper outer quadrant of the left breast. There are no changes in the skin or nipple, and there is no palpable axillary adenopathy. Which of the following is the most likely diagnosis?</p>"
          },
          "image": [
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/3c9f842f5bbc2d1af5bdd55291d9e5e3.jpg"
            },
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/caecf612036ab13c456868bdf70e4936.jpg"
            }
          ],
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Fibroadenoma</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Fibrocystic changes of the breast</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Infiltrating ductal carcinoma</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Intraductal papilloma</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Lobular carcinoma</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Fibroadenoma<br/><p><span style=\"color: rgb(230, 0, 0);\">Fibroadenomas are benign (not cancer) and don’t increase the risk of developing breast cancer</span>. They are thought to occur because of an increased sensitivity to the female hormone estrogen. A fibroadenoma usually has a smooth rubbery texture and can move easily under the skin. Fibroadenomas are usually painless, but some people may feel some tenderness or even pain. Fibroadenomas are very common and it is not unusual to have more than one. Often developing during puberty, they are mostly found in young women, but can occur at any age. Most fibroadenomas are about 1 to 3cm in size and are called simple fibroadenomas. Occasionally, a <span style=\"color: rgb(230, 0, 0);\">fi</span><strong style=\"color: rgb(230, 0, 0);\">broadenoma can grow to more than 5cm and may be called a giant fibroadenoma. Those found in teenage girls may be called juvenile fibroadenomas. Most fibroadenomas</strong> stay the same size. Some get smaller and some eventually disappear over time. Sometimes fibroadenomas get bigger, particularly in teenage girls and pregnant and breastfeeding women, but often get smaller again.</p><p><a href=\"https://breastcancernow.org/sites/default/files/publications/pdf/bcc72_fibroadenoma_2019_web.pdf\" target=\"_blank\">https://breastcancernow.org/sites/default/files/publications/pdf/bcc72_fibroadenoma_2019_web.pdf</a></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Fibroadenoma<br/><p><span style=\"color: rgb(230, 0, 0);\">Fibroadenomas are benign (not cancer) and don’t increase the risk of developing breast cancer</span>. They are thought to occur because of an increased sensitivity to the female hormone estrogen. A fibroadenoma usually has a smooth rubbery texture and can move easily under the skin. Fibroadenomas are usually painless, but some people may feel some tenderness or even pain. Fibroadenomas are very common and it is not unusual to have more than one. Often developing during puberty, they are mostly found in young women, but can occur at any age. Most fibroadenomas are about 1 to 3cm in size and are called simple fibroadenomas. Occasionally, a <span style=\"color: rgb(230, 0, 0);\">fi</span><strong style=\"color: rgb(230, 0, 0);\">broadenoma can grow to more than 5cm and may be called a giant fibroadenoma. Those found in teenage girls may be called juvenile fibroadenomas. Most fibroadenomas</strong> stay the same size. Some get smaller and some eventually disappear over time. Sometimes fibroadenomas get bigger, particularly in teenage girls and pregnant and breastfeeding women, but often get smaller again.</p><p><a href=\"https://breastcancernow.org/sites/default/files/publications/pdf/bcc72_fibroadenoma_2019_web.pdf\" target=\"_blank\">https://breastcancernow.org/sites/default/files/publications/pdf/bcc72_fibroadenoma_2019_web.pdf</a></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">42. A 50 year woman who was treated for breast cancer 3 years ago now presents with increase thirst and confusion. She has become drowsy now. What is the most likely metabolic abnormality?<br />\nclick below image to enlarge view for clinical manifestations of hypercalcemia</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/94c9a4bf335ea5eb6c9c2f18299377e7.jpg"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Hypercalcemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Hyperkalemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Hypoglycemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Hyperglycemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Hypocalcemia</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Hypercalcemia<br/>likely bone metastasis.its common in cancer patient.sign and symptoms are of Hypercalcemia and presence of Hypercalcemia in such patients carries poor prognosis.<br />\nUrgent treatment of severe hypercalcemia (Ca > 12 mg/dL): This includes the simultaneous IV administration<br />\nof saline, calcitonin (effective &lt; 48 hours), and a bisphosphonate. Isotonic saline corrects possible volume<br />\ndepletion due to hypercalcemia-induced urinary salt wasting or vomiting. Hypovolemia exacerbates hypercalcemia<br />\nby impairing the renal clearance of calcium..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Hypercalcemia<br/>likely bone metastasis.its common in cancer patient.sign and symptoms are of Hypercalcemia and presence of Hypercalcemia in such patients carries poor prognosis.<br />\nUrgent treatment of severe hypercalcemia (Ca > 12 mg/dL): This includes the simultaneous IV administration<br />\nof saline, calcitonin (effective &lt; 48 hours), and a bisphosphonate. Isotonic saline corrects possible volume<br />\ndepletion due to hypercalcemia-induced urinary salt wasting or vomiting. Hypovolemia exacerbates hypercalcemia<br />\nby impairing the renal clearance of calcium..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">43. A female 30 years old with breast cancer,given her blood workup and revealed low Hb, rest basic blood workup is normal.what is the next step in management?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Staging</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Lumpectomy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Mastectomy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Chemotherapy</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Staging<br/>A always first do staging workup for any malignancy case because treatment differs in different stages means stage 1 breast cancer first is surgery but in stage 3 breast cancer first treatment would be neoadjuvant chemotherapy then surgery and radiotherapy..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Staging<br/>A always first do staging workup for any malignancy case because treatment differs in different stages means stage 1 breast cancer first is surgery but in stage 3 breast cancer first treatment would be neoadjuvant chemotherapy then surgery and radiotherapy..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">44. A 23-year-old woman comes to the emergency department with markedly increased menstrual bleeding, gum bleeding when she brushes her teeth and petechiae on physical examination. Physical examination is otherwise normal. The platelet count is 17,000/cumm,What is the most appropriate next step in therapy?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Bone marrow biopsy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Intravenous immunoglobulins\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Prednisone</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Antiplatelet antibodies\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Platelet transfusion\n</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Prednisone<br/><p>The bleeding, in this case, is mild, meaning there is no intracranial bleeding or major GI bleeding, and the platelet is not profoundly low. Prednisone is the best initial therapy. Initiating prednisone is more important than checking for increased megakaryocytes or the presence of antiplatelet antibodies, which is characteristic of ITP. Bone marrow is rarely needed.&nbsp;</p><h4><strong style=\"color: rgb(230, 0, 0);\">Diagnostic Tests Idiopathic thrombocytopenic purpura (ITP)</strong></h4><ul><li>ITP is a diagnosis of exclusion. Occasional diagnostic tests are: Antiplatelet antibodies lack specificity, limited benefit. Ultrasound or CT scan to exclude hypersplenism Megakaryocytes are elevated in number. Bone marrow, not routine; indicated only before splenectomy Increase in mean platelet volume</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">Treatment</strong></p><p>Presentation Management</p><ul><li>No bleeding, count &gt;30,000 -No treatment</li><li>Mild bleeding, count &lt;30,000 Glucocorticoids</li><li>Severe bleeding (GI/CNS), count &lt;10,000 IVIG,</li><li>Anti-Rho (anti-D)</li><li>Recurrent episodes, steroid-dependent- Splenectomy</li><li>Splenectomy or steroids not effective Romiplostim or eltrombopag, rituximab, azathioprine, cyclosporine, mycophenolate</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">TIPS</strong></p><ol><li>ITP is a diagnosis of exclusion</li><li>ITP has no lymphadenopathy no hepatomegaly</li><li>CBC showed only low Platelet count(isolated thrombocytopenia), HB and WBC is normal</li><li>Bone marrow showed-increase number of Megakaryocytes with normal morphology</li><li>The steroid is the first-line treatment and if fails splenectomy is the best next option</li><li>Platelets are large in ITP.</li><li>Before splenectomy, give vaccination to Neisseria meningitides Haemophilus influenza Pneumococcus</li><li>Romiplostim and eltrombopag are synthetic thrombopoietins for ITP.&nbsp;</li></ol><p><br></p><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Prednisone<br/><p>The bleeding, in this case, is mild, meaning there is no intracranial bleeding or major GI bleeding, and the platelet is not profoundly low. Prednisone is the best initial therapy. Initiating prednisone is more important than checking for increased megakaryocytes or the presence of antiplatelet antibodies, which is characteristic of ITP. Bone marrow is rarely needed.&nbsp;</p><h4><strong style=\"color: rgb(230, 0, 0);\">Diagnostic Tests Idiopathic thrombocytopenic purpura (ITP)</strong></h4><ul><li>ITP is a diagnosis of exclusion. Occasional diagnostic tests are: Antiplatelet antibodies lack specificity, limited benefit. Ultrasound or CT scan to exclude hypersplenism Megakaryocytes are elevated in number. Bone marrow, not routine; indicated only before splenectomy Increase in mean platelet volume</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">Treatment</strong></p><p>Presentation Management</p><ul><li>No bleeding, count &gt;30,000 -No treatment</li><li>Mild bleeding, count &lt;30,000 Glucocorticoids</li><li>Severe bleeding (GI/CNS), count &lt;10,000 IVIG,</li><li>Anti-Rho (anti-D)</li><li>Recurrent episodes, steroid-dependent- Splenectomy</li><li>Splenectomy or steroids not effective Romiplostim or eltrombopag, rituximab, azathioprine, cyclosporine, mycophenolate</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">TIPS</strong></p><ol><li>ITP is a diagnosis of exclusion</li><li>ITP has no lymphadenopathy no hepatomegaly</li><li>CBC showed only low Platelet count(isolated thrombocytopenia), HB and WBC is normal</li><li>Bone marrow showed-increase number of Megakaryocytes with normal morphology</li><li>The steroid is the first-line treatment and if fails splenectomy is the best next option</li><li>Platelets are large in ITP.</li><li>Before splenectomy, give vaccination to Neisseria meningitides Haemophilus influenza Pneumococcus</li><li>Romiplostim and eltrombopag are synthetic thrombopoietins for ITP.&nbsp;</li></ol><p><br></p><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">45. Adjuvant chemotherapy is of definite value in in which of the following cancer?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Cancer colon</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Cancer pancreas</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Cancer gall bladder</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Cancer oesophagus</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Cancer colon<br/>The most important prognostic factor in anticipating the risk of recurrence is the stage of the tumor at the time of resection [3, 4]. Tumors which do not penetrate the full thickness of the bowel wall and which have not spread to local regional lymph nodes (T1-2N0M0, modified Astler-Coller Dukes stages A and B1) typically have in excess of a 90% cure rate with surgery alone [4], and postoperative therapy is not routinely recommended. It is in the higher-risk tumors with either full thickness penetration of the bowel wall (T3-4N0M0, modified Astler-Coller Dukes B2-3, stage II) and/or local regional lymph node involvement (TanyN1-2M0, modified Astler-Coller Dukes C, stage III) that the risk of recurrent disease increases, and adjuvant therapy is potentially indicated. <br />\n<br />\nAdjuvant chemotherapy of colorectal cancer, although far from satisfactory, has been clearly shown to reduce the incidence of recurrence and to save lives..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Cancer colon<br/>The most important prognostic factor in anticipating the risk of recurrence is the stage of the tumor at the time of resection [3, 4]. Tumors which do not penetrate the full thickness of the bowel wall and which have not spread to local regional lymph nodes (T1-2N0M0, modified Astler-Coller Dukes stages A and B1) typically have in excess of a 90% cure rate with surgery alone [4], and postoperative therapy is not routinely recommended. It is in the higher-risk tumors with either full thickness penetration of the bowel wall (T3-4N0M0, modified Astler-Coller Dukes B2-3, stage II) and/or local regional lymph node involvement (TanyN1-2M0, modified Astler-Coller Dukes C, stage III) that the risk of recurrent disease increases, and adjuvant therapy is potentially indicated. <br />\n<br />\nAdjuvant chemotherapy of colorectal cancer, although far from satisfactory, has been clearly shown to reduce the incidence of recurrence and to save lives..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">46. A patient has carcinoma of right side tongue on its lateral border of anterior 2/3rd, with lymph node of size 4 cm in level 3 on the same side of the neck, stage of disease is</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. N0</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. N1</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. N2</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. N3</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : N2<br/>N2<br />\nAJCC staging for oral cavity tumours:<br />\nN0 – No clinically palpable lymph nodes<br />\nN1 – Single ipsilateral node less than 3cm<br />\nN2a – Single ipsilateral lymph node 3-6cm<br />\nN2b – Multiple ipsilateral lymph nodes less than 6cm<br />\nN2c – Bilateral / Contralateral lymph nodes less than 6cm<br />\nN3 – Nodes more than 6cm<br />\n<br />\nTx<br />\nThe doctor is unable to assess the primary tumor.<br />\nT0<br />\nThe doctor is unable to find the primary tumor.<br />\nTis<br />\nCarcinoma in situ (or severe dysplasia); this means there are cancer type cells, but they have not yet invaded deep into tissue. This is more of a pre-cancer lesion.<br />\nT1<br />\nThe tumor is 2 centimeters or less in greatest dimension.<br />\nT2<br />\nThe tumor is more than 2 centimeters but less than or equal to 4 centimeters in greatest dimension.<br />\nT3<br />\nThe tumor is more than 4 centimeters in greatest dimension.<br />\nT4a<br />\nThis is moderately advanced local disease. The tumor clearly invades into the skin of the face, through the upper or lower jawbone, into the nerve that allows you to feel the teeth and chin area or into the floor of the mouth.Note: A little bit of bone or tooth socket invasion from a tumor of the gums does NOT make it a T4a cancer.<br />\nT4b<br />\nThis is very advanced local disease. This stage is assigned if the tumor is invading into the masticator space, pterygoid plates, base of the skull and/or encases the carotid artery.<br />\n<br><a target=\"_blank\" href=\"https://headandneckcancerguide.org/adults/introduction-to-head-and-neck-cancer/oral-cancers/tongue-cancer/stage-cancer/\">https://headandneckcancerguide.org/adults/introduction-to-head-and-neck-cancer/oral-cancers/tongue-cancer/stage-cancer/</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : N2<br/>N2<br />\nAJCC staging for oral cavity tumours:<br />\nN0 – No clinically palpable lymph nodes<br />\nN1 – Single ipsilateral node less than 3cm<br />\nN2a – Single ipsilateral lymph node 3-6cm<br />\nN2b – Multiple ipsilateral lymph nodes less than 6cm<br />\nN2c – Bilateral / Contralateral lymph nodes less than 6cm<br />\nN3 – Nodes more than 6cm<br />\n<br />\nTx<br />\nThe doctor is unable to assess the primary tumor.<br />\nT0<br />\nThe doctor is unable to find the primary tumor.<br />\nTis<br />\nCarcinoma in situ (or severe dysplasia); this means there are cancer type cells, but they have not yet invaded deep into tissue. This is more of a pre-cancer lesion.<br />\nT1<br />\nThe tumor is 2 centimeters or less in greatest dimension.<br />\nT2<br />\nThe tumor is more than 2 centimeters but less than or equal to 4 centimeters in greatest dimension.<br />\nT3<br />\nThe tumor is more than 4 centimeters in greatest dimension.<br />\nT4a<br />\nThis is moderately advanced local disease. The tumor clearly invades into the skin of the face, through the upper or lower jawbone, into the nerve that allows you to feel the teeth and chin area or into the floor of the mouth.Note: A little bit of bone or tooth socket invasion from a tumor of the gums does NOT make it a T4a cancer.<br />\nT4b<br />\nThis is very advanced local disease. This stage is assigned if the tumor is invading into the masticator space, pterygoid plates, base of the skull and/or encases the carotid artery.<br />\n<br><a target=\"_blank\" href=\"https://headandneckcancerguide.org/adults/introduction-to-head-and-neck-cancer/oral-cancers/tongue-cancer/stage-cancer/\">https://headandneckcancerguide.org/adults/introduction-to-head-and-neck-cancer/oral-cancers/tongue-cancer/stage-cancer/</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">47. Pancytopenia, iron deficiency anemia, Thrombosis, episodic dark urine, high LDH is classical seen in which of the following?</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/0889e3ecdede769252d7d7cb53343fda.jpg"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Aplastic anemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. PNH(Paroxysmal nocturnal hemoglobinuria)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. MDS(Myelo dysplastic Syndrome)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Acute leukemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. None of the Above</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : PNH(Paroxysmal nocturnal hemoglobinuria)<br/>Paroxysmal Nocturnal Hemoglobinuria CD55/CD59 proteins (also known as decay accelerating factor) found on the surface of RBCs protect them from complement-mediated hemolysis. Paroxysmal nocturnal hemoglobinuria (PNH) is a deficiency in glycosylphosphatidylinositol-anchor molecules that inhibit CD55/CD59 attachment or binding to RBCs, resulting in complement-mediated hemolysis and thrombosis. <br />\n-Hx/PE: PNH can manifest as iron deficiency anemia, episodic dark urine, venous thrombosis (most commonly mesenteric and hepatic vein thrombosis), pancytopenia, and abdominal pain. <br />\n<br />\n-Diagnosis- Most accurate diagnostic test is CD55/CD59 absence via flow cytometry. <br />\n-Treatment: Prednisone is the best initial therapy. Allogeneic bone marrow transplant is curative. Eculizumab, a complement inhibitor, can be used for hemolysis and thrombosis..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : PNH(Paroxysmal nocturnal hemoglobinuria)<br/>Paroxysmal Nocturnal Hemoglobinuria CD55/CD59 proteins (also known as decay accelerating factor) found on the surface of RBCs protect them from complement-mediated hemolysis. Paroxysmal nocturnal hemoglobinuria (PNH) is a deficiency in glycosylphosphatidylinositol-anchor molecules that inhibit CD55/CD59 attachment or binding to RBCs, resulting in complement-mediated hemolysis and thrombosis. <br />\n-Hx/PE: PNH can manifest as iron deficiency anemia, episodic dark urine, venous thrombosis (most commonly mesenteric and hepatic vein thrombosis), pancytopenia, and abdominal pain. <br />\n<br />\n-Diagnosis- Most accurate diagnostic test is CD55/CD59 absence via flow cytometry. <br />\n-Treatment: Prednisone is the best initial therapy. Allogeneic bone marrow transplant is curative. Eculizumab, a complement inhibitor, can be used for hemolysis and thrombosis..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">48. Pregnant women need how much amount of iron per day?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. 1-2 mg</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. 2-3 mg</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. 5-6 mg</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. 6-10mg</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : 5-6 mg<br/>Iron is absorbed from duodenum and can absorb maximum 4mg per day,in male normally 1-2 mg/day is required in menstruation woman 2-3 mg/day is required and in pregnant woman 5-6mg/day is required.<br />\nRef-MTB page 225.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : 5-6 mg<br/>Iron is absorbed from duodenum and can absorb maximum 4mg per day,in male normally 1-2 mg/day is required in menstruation woman 2-3 mg/day is required and in pregnant woman 5-6mg/day is required.<br />\nRef-MTB page 225.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">49. Which of the following is most commonly seen in B12 deficiency?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Peripheral neuropathy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Dementia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Posterior column damage</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. None of above</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Peripheral neuropathy<br/>A lack of B12 damages the myelin sheath that surrounds and protect nerves. Without this protection, nerves cease to function properly and conditions such as peripheral neuropathy occur. ... The nerve damage caused by a lack of B12 may become permanently debilitating, if the underlying condition is not treated.<br />\n<br />\nSupplementation should include vitamin B-1 (thiamine and benfotiamine), B-6, and B-12. ... A deficiency in vitamin B-12 is one cause of peripheral neuropathy. Left untreated, it can cause permanent nerve damage. Vitamin B-6 may help to maintain the covering on nerve endings..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Peripheral neuropathy<br/>A lack of B12 damages the myelin sheath that surrounds and protect nerves. Without this protection, nerves cease to function properly and conditions such as peripheral neuropathy occur. ... The nerve damage caused by a lack of B12 may become permanently debilitating, if the underlying condition is not treated.<br />\n<br />\nSupplementation should include vitamin B-1 (thiamine and benfotiamine), B-6, and B-12. ... A deficiency in vitamin B-12 is one cause of peripheral neuropathy. Left untreated, it can cause permanent nerve damage. Vitamin B-6 may help to maintain the covering on nerve endings..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">50. Which of the following deficiency cause increase in Methylmalonic acid level?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Alpha thalassemia-3 gene deletion</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Beta Thalassemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. B12 deficiency</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Folate deficiency</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Iron defeiciency</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : B12 deficiency<br/>B12 and Folic acid Hemaatological picture is same.,homocystine level raised in both B12 and Folate deficiency but MMA increased only in B12 deficiency can be helpful in b12 suspectedd patient with normal level or post B12 administration.<br />\nHypersegmented Neutrophils seen only in b12 deficiency not Folate.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : B12 deficiency<br/>B12 and Folic acid Hemaatological picture is same.,homocystine level raised in both B12 and Folate deficiency but MMA increased only in B12 deficiency can be helpful in b12 suspectedd patient with normal level or post B12 administration.<br />\nHypersegmented Neutrophils seen only in b12 deficiency not Folate.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">51. Most accurate test for hereditary Spherocytosis is?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. CBC and Peipheral smear</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Hemoglobin Electophoresis</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Retic count high</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Osmotic Fragility</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Genetic study</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : Osmotic Fragility<br/>D ostmtic fragility-when cells are placed in Hypotonic solution,they increase in size and casuehemolysis.Heridietary spherocytosis is membrane shape means spherical shape RBC instead of biconcave or dumbel shape RBC ,,its not genetic defect like thalassemia or sickle cell in rbc so geneetic test has no value and rest other tests are not as specific as osmotic fragility so best amongst all option is Oprion D.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : Osmotic Fragility<br/>D ostmtic fragility-when cells are placed in Hypotonic solution,they increase in size and casuehemolysis.Heridietary spherocytosis is membrane shape means spherical shape RBC instead of biconcave or dumbel shape RBC ,,its not genetic defect like thalassemia or sickle cell in rbc so geneetic test has no value and rest other tests are not as specific as osmotic fragility so best amongst all option is Oprion D.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">52. Autoimmune hemolysis (Warm or IgG) best test is?</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/dfb505d50219e9c7c6c98a55b3925b58.png"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Coomb’s test</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. High reticulocyte count</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. CBC and Peripheral smear</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Hemoglobin electrophoresis</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Coomb’s test<br/>Coomb’s tests detects IgG antibodies on surface of red cells the direct and indirect tests tells basically the same things but Indirect test is associated with greater amount of antibodies.<br />\nGlucocorticoid is best initial treatment and in recurrent cases Splenectomy.<br />\nNote-Steroid and Splenectomy do not works in Cold (igM) agglutinin disease.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Coomb’s test<br/>Coomb’s tests detects IgG antibodies on surface of red cells the direct and indirect tests tells basically the same things but Indirect test is associated with greater amount of antibodies.<br />\nGlucocorticoid is best initial treatment and in recurrent cases Splenectomy.<br />\nNote-Steroid and Splenectomy do not works in Cold (igM) agglutinin disease.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">53. A 54-year-old man comes to the emergency department for shortness of breath, blurry vision, confusion, and priapism. His<br />\nWBC count is found to be 225,000/?L. The cells are predominantly neutrophils with about 4% blasts.<br />\nWhat is the most appropriate next step in the management of this case?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Leukapheresis</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. BCR-ABL testing.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Bone marrow biopsy.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Bone marrow transplant</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Flow cytometry.\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">F. Hydroxyurea.</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Leukapheresis<br/>In acute leukostasis reaction, it is more important to remove the excessive white blood cells from the blood than to<br />\nestablish a specific diagnosis. Specific testing is not as important as treatment. No matter what the etiology, you still have to take the cells off. The symptoms are caused by blocking the delivery of oxygen to tissues because the red blood cells simply cannot get to the tissues. Afterward, you can establish a specific diagnosis. Hydroxyurea will lower the cell count, but not as rapidly as leukapheresis..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Leukapheresis<br/>In acute leukostasis reaction, it is more important to remove the excessive white blood cells from the blood than to<br />\nestablish a specific diagnosis. Specific testing is not as important as treatment. No matter what the etiology, you still have to take the cells off. The symptoms are caused by blocking the delivery of oxygen to tissues because the red blood cells simply cannot get to the tissues. Afterward, you can establish a specific diagnosis. Hydroxyurea will lower the cell count, but not as rapidly as leukapheresis..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">54. Patient with macrocytic anemia without megaloblasts. What’s the most likely diagnosis?<br />\nclick below image to enlarge view.</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/8e0c58cf211dcbf971a3923f331c6d57.jpg"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Folic acid</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Vitamin B12 deficiency</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Alcoholism</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Iron deficiency</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Thalassemia Trait</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Alcoholism<br/>Macrocytosis means-MCV is more than 100fl(normal is 80-100)<br />\nMicrocytosis means-MCV less than 80 (MCV=Mean Corpuscular volume-measured by Automated machine when we order CBC)<br />\n<br />\nAlcoholism is macrocytic anemia but not megaloblastic anemia while A and B is with megaloblastic anemia.<br />\nMegaloblastic anemia is the presence of hypersegmented neutrophils. Many factors raise the MCV, but only B12 and folate<br />\ndeficiency and antimetabolite medications cause hypersegmentation..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Alcoholism<br/>Macrocytosis means-MCV is more than 100fl(normal is 80-100)<br />\nMicrocytosis means-MCV less than 80 (MCV=Mean Corpuscular volume-measured by Automated machine when we order CBC)<br />\n<br />\nAlcoholism is macrocytic anemia but not megaloblastic anemia while A and B is with megaloblastic anemia.<br />\nMegaloblastic anemia is the presence of hypersegmented neutrophils. Many factors raise the MCV, but only B12 and folate<br />\ndeficiency and antimetabolite medications cause hypersegmentation..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">55. Patient had Atrial fibrillation on warfarin presented with bacterial pharyngitis.you have Prescribed augmentin, INR 2.7, what to do:</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Low dose augmentin</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Decrease the dose of warfarin</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Stop warfarin for 4 days</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Check INR after 3 days</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Decrease the dose of warfarin<br/>B as amugmentin reduces vit k absorption and increast INR has risk of bleeding..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Decrease the dose of warfarin<br/>B as amugmentin reduces vit k absorption and increast INR has risk of bleeding..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">56. Normal PSA is up to 4, PSA of 8 is diagnostic test for which of the following condition in asymptomatic patient?<br />\n(PSA= Prostate Specific Antigen).Click below image to enlarge view.</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/6c940c5cb877e05e25f442046ba4e524.png"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Prostatitis</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. BPH (benigh Prostatic Hypertrophy)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Prostate cancer</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Can be any of above</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : Can be any of above<br/>PSA can increase without cancer in below candition<br />\n<br />\n1-Age. PSA levels may increase as you get older. ...<br />\n2-Benign prostatic hyperplasia (BPH) ...<br />\n3-Urinary Tract Infection (UTI) ...<br />\n4-Prostatitis (prostate inflammation)or inflammation<br />\n5-Ejaculation. ...<br />\n6-Parathyroid hormone. ...<br />\n7-Prostate Injury. ...<br />\n8-Surgical procedures.<br />\n9-vigorous excercise or cycling<br />\n10-Anal sex<br />\n<br />\nAlso it can increase in prostate cancer<br />\n<br />\nDiagnosis of prostate cancer<br />\n-Suggested by clinical findings and/or a markedly increased PSA (> 4 ng/mL).<br />\n-Most accurate test: Ultrasound-guided transrectal biopsy.<br />\n-Tumors are graded by the Gleason histologic system, which sums the scores <br />\n(from 1 to 5) of the two most dysplastic samples (10 is the highest grade).<br />\n-Look for metastases with CT of the abdomen/pelvis and bone scan (metastatic lesions show an osteoblastic).<br />\n<br />\n<br />\nAn increase in PSA can be caused by BPH, prostatitis, prostatic trauma, or Prostatic carcinoma<br />\nBone is commonest site for metastasis in prostate cancer.<br />\n<br><a target=\"_blank\" href=\"https://scienceblog.cancerresearchuk.org/2018/03/06/why-a-one-off-psa-test-for-prostate-cancer-is-doing-men-more-harm-than-good/\">https://scienceblog.cancerresearchuk.org/2018/03/06/why-a-one-off-psa-test-for-prostate-cancer-is-doing-men-more-harm-than-good/</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : Can be any of above<br/>PSA can increase without cancer in below candition<br />\n<br />\n1-Age. PSA levels may increase as you get older. ...<br />\n2-Benign prostatic hyperplasia (BPH) ...<br />\n3-Urinary Tract Infection (UTI) ...<br />\n4-Prostatitis (prostate inflammation)or inflammation<br />\n5-Ejaculation. ...<br />\n6-Parathyroid hormone. ...<br />\n7-Prostate Injury. ...<br />\n8-Surgical procedures.<br />\n9-vigorous excercise or cycling<br />\n10-Anal sex<br />\n<br />\nAlso it can increase in prostate cancer<br />\n<br />\nDiagnosis of prostate cancer<br />\n-Suggested by clinical findings and/or a markedly increased PSA (> 4 ng/mL).<br />\n-Most accurate test: Ultrasound-guided transrectal biopsy.<br />\n-Tumors are graded by the Gleason histologic system, which sums the scores <br />\n(from 1 to 5) of the two most dysplastic samples (10 is the highest grade).<br />\n-Look for metastases with CT of the abdomen/pelvis and bone scan (metastatic lesions show an osteoblastic).<br />\n<br />\n<br />\nAn increase in PSA can be caused by BPH, prostatitis, prostatic trauma, or Prostatic carcinoma<br />\nBone is commonest site for metastasis in prostate cancer.<br />\n<br><a target=\"_blank\" href=\"https://scienceblog.cancerresearchuk.org/2018/03/06/why-a-one-off-psa-test-for-prostate-cancer-is-doing-men-more-harm-than-good/\">https://scienceblog.cancerresearchuk.org/2018/03/06/why-a-one-off-psa-test-for-prostate-cancer-is-doing-men-more-harm-than-good/</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">57. Which of the following is the most useful to determine dosing of chemotherapy in Hodgkins disease?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Echocardiogram.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Bone marrow biopsy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Gender.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. MUGA or nuclear ventriculogram.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Hematocrit.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">F. Symptoms</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : MUGA or nuclear ventriculogram.<br/>Adriamycin (or doxorubicin) is cardiotoxic. The nuclear ventriculogram is the most accurate method of assessing left<br />\nventricular ejection fraction. Use the MUGA scan to determinewhether cardiac toxicity has occurred prior to the development of<br />\nsymptoms. You can’t use adriamycin if the ejection fraction is less than 50%.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : MUGA or nuclear ventriculogram.<br/>Adriamycin (or doxorubicin) is cardiotoxic. The nuclear ventriculogram is the most accurate method of assessing left<br />\nventricular ejection fraction. Use the MUGA scan to determinewhether cardiac toxicity has occurred prior to the development of<br />\nsymptoms. You can’t use adriamycin if the ejection fraction is less than 50%.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">58. The most common malignant neoplasm of infancy is:</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Malignant teratoma</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Neuroblastoma</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Wilm’s tumor</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Hepatoblastoma</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Neuroblastoma<br/>Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue.It most frequently starts from one of the adrenal glands but can also develop in the neck, chest, abdomen, or spine.Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under the skin.<br />\n<br />\nPrognosis<br />\nBetween 20% and 50% of high-risk cases do not respond adequately to induction high-dose chemotherapy and are progressive or refractory.Relapse after completion of frontline therapy is also common. <br />\n<br />\nMost long-term survivors alive today had low or intermediate risk disease and milder courses of treatment compared to high-risk disease. The majority of survivors have long-term effects from the treatment. Survivors of intermediate and high-risk treatment often experience hearing loss, growth reduction, thyroid function disorders, learning difficulties, and greater risk of secondary cancers affect survivors of high-risk disease.An estimated two of three survivors of childhood cancer will ultimately develop at least one chronic and sometimes life-threatening health problem within 20 to 30 years after the cancer diagnosis..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Neuroblastoma<br/>Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue.It most frequently starts from one of the adrenal glands but can also develop in the neck, chest, abdomen, or spine.Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under the skin.<br />\n<br />\nPrognosis<br />\nBetween 20% and 50% of high-risk cases do not respond adequately to induction high-dose chemotherapy and are progressive or refractory.Relapse after completion of frontline therapy is also common. <br />\n<br />\nMost long-term survivors alive today had low or intermediate risk disease and milder courses of treatment compared to high-risk disease. The majority of survivors have long-term effects from the treatment. Survivors of intermediate and high-risk treatment often experience hearing loss, growth reduction, thyroid function disorders, learning difficulties, and greater risk of secondary cancers affect survivors of high-risk disease.An estimated two of three survivors of childhood cancer will ultimately develop at least one chronic and sometimes life-threatening health problem within 20 to 30 years after the cancer diagnosis..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">59. What is the explanation for the difference between the urinary level of protein on urinalysis and the 24-hour urine?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. False positive 24-hour urine is common in myeloma.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Calcium in urine creates a false negative urinalysis</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Uric acid creates a false positive 24-hour urine.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Bence-Jones protein is not detected by dipstick.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. IgG in urine inactivates the urine dipstick.</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : Bence-Jones protein is not detected by dipstick.<br/>Bence-Jones protein is detected by urine immunoelectrophoresis. The urine dipstick will detect only albumin..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : Bence-Jones protein is not detected by dipstick.<br/>Bence-Jones protein is detected by urine immunoelectrophoresis. The urine dipstick will detect only albumin..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">60. What is the single most accurate test for myeloma?</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/00a94bf7c6dd9436a84ce6e726a2809c.png"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Skull x-rays</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Bone marrow biopsy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. 24-hour urine</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. SPEP(Serum Protein Electrophoresis)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Urine immunoelectrophoresis (Bence-Jones protein)</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Bone marrow biopsy<br/><p><a href=\"https://www.myeloma.org/what-are-mgus-smm-mm\" target=\"_blank\">What Are MGUS, Smoldering and Active Myeloma? | The IMF</a></p><p><br></p><p>Nothing besides myeloma is associated with <strong style=\"color: rgb(230, 0, 0);\">greater than 10% plasma cells on bone marrow biopsy.</strong> The most common wrong answer is SPEP. Of those with an “M-spike” of immunoglobulins, 99% do not have myeloma. Most IgG spikes are from monoclonal gammopathy of unknown significance that does not progress or need treatment. Skull x-rays show lytic lesions, but this is not as specific as massive plasma cell levels in the marrow. </p><p><strong style=\"color: rgb(230, 0, 0);\">Treatment </strong>The best initial therapy is a combination of dexamethasone with lenalidomide, bortezomib, or both. The most effective therapy in those under age 70 is an autologous bone marrow transplant with stem cell support. This is used after induction chemotherapy with lenalidomide and steroids. Daratumumab is an anti-CD38 drug used in relapse. Bortezomib use has a high risk of inducing neurological complications. Thalidomide and lenalidomide have a high risk of increasing clotting. Give prophylaxis against clotting when using thalidomide or lenalidomide.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Bone marrow biopsy<br/><p><a href=\"https://www.myeloma.org/what-are-mgus-smm-mm\" target=\"_blank\">What Are MGUS, Smoldering and Active Myeloma? | The IMF</a></p><p><br></p><p>Nothing besides myeloma is associated with <strong style=\"color: rgb(230, 0, 0);\">greater than 10% plasma cells on bone marrow biopsy.</strong> The most common wrong answer is SPEP. Of those with an “M-spike” of immunoglobulins, 99% do not have myeloma. Most IgG spikes are from monoclonal gammopathy of unknown significance that does not progress or need treatment. Skull x-rays show lytic lesions, but this is not as specific as massive plasma cell levels in the marrow. </p><p><strong style=\"color: rgb(230, 0, 0);\">Treatment </strong>The best initial therapy is a combination of dexamethasone with lenalidomide, bortezomib, or both. The most effective therapy in those under age 70 is an autologous bone marrow transplant with stem cell support. This is used after induction chemotherapy with lenalidomide and steroids. Daratumumab is an anti-CD38 drug used in relapse. Bortezomib use has a high risk of inducing neurological complications. Thalidomide and lenalidomide have a high risk of increasing clotting. Give prophylaxis against clotting when using thalidomide or lenalidomide.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">61. For colon cancer which is the prognostic factor for recurrence?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Age</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Family History</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Stage</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Sex</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Stage<br/>What is a 5-year relative survival rate?<br />\nA relative survival rate compares people with the same type and stage of colon or rectal cancer to people in the overall population. For example, if the 5-year relative survival rate for a specific stage of colon or rectal cancer is 80%, it means that people who have that cancer are, on average, about 80% as likely as people who don’t have that cancer to live for at least 5 years after being diagnosed. <br />\n<br />\n5-year relative survival rates for colon cancer<br />\n(Based on people diagnosed with cancers of the colon between 2008 and 2014.)<br />\n<br />\n<br />\nSEER stage<br />\n5-year relative survival rate<br />\nLocalized<br />\n90%<br />\nRegional<br />\n71%<br />\nDistant<br />\n14%<br />\nAll SEER stages combined<br />\n64%.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Stage<br/>What is a 5-year relative survival rate?<br />\nA relative survival rate compares people with the same type and stage of colon or rectal cancer to people in the overall population. For example, if the 5-year relative survival rate for a specific stage of colon or rectal cancer is 80%, it means that people who have that cancer are, on average, about 80% as likely as people who don’t have that cancer to live for at least 5 years after being diagnosed. <br />\n<br />\n5-year relative survival rates for colon cancer<br />\n(Based on people diagnosed with cancers of the colon between 2008 and 2014.)<br />\n<br />\n<br />\nSEER stage<br />\n5-year relative survival rate<br />\nLocalized<br />\n90%<br />\nRegional<br />\n71%<br />\nDistant<br />\n14%<br />\nAll SEER stages combined<br />\n64%.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">62. 65 year’s old rich man recently diagnosed with Hepatocellular carcinoma.regarding telling the patient about his diagnosis, One of the following is true?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Inform him directly after confirmation of the diagnosis regardless of his wishes</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Only the patient family should be informed</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. 50% survival rate should be calculated as recent study and discussed with the patient</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. The responsibility should be conducted by the social worker</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Inform the patient according to his moral, knowledge and psychiatric conditions</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is E : Inform the patient according to his moral, knowledge and psychiatric conditions.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is E : Inform the patient according to his moral, knowledge and psychiatric conditions.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">63. What is the best screening for Hepato cellular carcinoma?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Ultrasound and AFP level</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Ultra sound</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. AFP level</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. History, examination and positivity of Hbsag</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Ultrasound and AFP level<br/>THE SCREENING TEST MUST HAVE A LOW MORBIDITY AND HIGH SENSITIVITY AND SPECIFICITY<br />\nThe most commonly used screening tests are serum Alpha-fetoprotein (AFP) and ultrasonography. In evaluating such tests, it is important to note that the performance characteristics of a test that is used for diagnosis may differ when used for screening/surveillance. Thus, reports of the performance characteristics of AFP and ultrasonography, when applied to screening/surveillance, must be interpreted cautiously..............http://www.hepatitiscentral.com/hcv/hcc/screening/for/.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Ultrasound and AFP level<br/>THE SCREENING TEST MUST HAVE A LOW MORBIDITY AND HIGH SENSITIVITY AND SPECIFICITY<br />\nThe most commonly used screening tests are serum Alpha-fetoprotein (AFP) and ultrasonography. In evaluating such tests, it is important to note that the performance characteristics of a test that is used for diagnosis may differ when used for screening/surveillance. Thus, reports of the performance characteristics of AFP and ultrasonography, when applied to screening/surveillance, must be interpreted cautiously..............http://www.hepatitiscentral.com/hcv/hcc/screening/for/.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">64. What is the initial treatment of newly diagnosed Acute Myeloid Leukemia (AML)?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Chemotherapy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Radiotherapy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Chemo and radiotherapy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Bone Marrow transplantation.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Gene therapy</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Chemotherapy<br/>Chemotherapy is best initial treatment of Acute Myeloid Leukemia (AML)and Lymphoid Leukemia (ALL).brain radiation can be used in Acute Lymphoblastic leukaemia as CNS prophylaxis but not in AML.<br />\n<br />\nBone marrow transplantation (BMT) can be done for Leukemia but not as initial treatment ,initial treatment is chemotherapy, BMT is offered to patient in relapse or refractory cases of Leukemia after initial chemotherapy,<br />\n<br />\nLeukemia vs lymphoma<br />\nLeukemia -Lymphoid or myeloid neoplasm with widespread involvement of bone marrow. Tumor cells are<br />\nusually found in peripheral blood.<br />\nLymphoma -Discrete tumor mass arising from lymph nodes. Presentations often blur definitions..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Chemotherapy<br/>Chemotherapy is best initial treatment of Acute Myeloid Leukemia (AML)and Lymphoid Leukemia (ALL).brain radiation can be used in Acute Lymphoblastic leukaemia as CNS prophylaxis but not in AML.<br />\n<br />\nBone marrow transplantation (BMT) can be done for Leukemia but not as initial treatment ,initial treatment is chemotherapy, BMT is offered to patient in relapse or refractory cases of Leukemia after initial chemotherapy,<br />\n<br />\nLeukemia vs lymphoma<br />\nLeukemia -Lymphoid or myeloid neoplasm with widespread involvement of bone marrow. Tumor cells are<br />\nusually found in peripheral blood.<br />\nLymphoma -Discrete tumor mass arising from lymph nodes. Presentations often blur definitions..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">65. Felty’s syndrome contains?</p>"
          },
          "image": [
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/00a36df629799e9e2e771e2ccd4f252e.jpg"
            },
            {
              "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/27c60a8c01b9845f892e9e9f07257dda.jpg"
            }
          ],
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Rhumatoidarthritis, Splenomegaly and high WBC count</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Rhumatoidarthritis, Splenomegaly and low WBC count</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Rhumatoidarthritis, hepatomegaly and high WBC count</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Splenomegaly and low WBC count only.</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Rhumatoidarthritis, Splenomegaly and low WBC count<br/><p>Felty's syndrome, also called Felty syndrome, (FS) is a rare autoimmune disease characterized by the triad of rheumatoid arthritis, enlargement of the spleen and too few neutrophils in the blood. The condition is more common in those aged 50–70 years, specifically more prevalent in females than males, and more so in Caucasians than those of African descent. It is a deforming disease that causes many complications for the individual. </p><p><strong style=\"color: rgb(230, 0, 0);\">Treatment</strong>-There is no real treatment for Felty's syndrome, rather the best method in the management of the disease is to control the underlying rheumatoid arthritis. Immunosuppressive therapy for RA often improves granulocytopenia and splenomegaly; this finding reflects the fact that Felty's syndrome is an immune-mediated disease. A major challenge in treating FS is a recurring infection caused by neutropenia. Therefore, in order to decide upon and begin treatment, the cause and relationship of neutropenia with the overall condition must be well understood.[8] Most of the traditional medications used to treat RA have been used in the treatment of Felty's syndrome. No well-conducted, randomized, controlled trials support the use of any single agent. Most reports on treatment regimens involve small numbers of patients. Splenectomy may improve neutropenia in severe disease. Use of rituximab and leflunomide have been proposed. Use of gold therapy has also been described.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Rhumatoidarthritis, Splenomegaly and low WBC count<br/><p>Felty's syndrome, also called Felty syndrome, (FS) is a rare autoimmune disease characterized by the triad of rheumatoid arthritis, enlargement of the spleen and too few neutrophils in the blood. The condition is more common in those aged 50–70 years, specifically more prevalent in females than males, and more so in Caucasians than those of African descent. It is a deforming disease that causes many complications for the individual. </p><p><strong style=\"color: rgb(230, 0, 0);\">Treatment</strong>-There is no real treatment for Felty's syndrome, rather the best method in the management of the disease is to control the underlying rheumatoid arthritis. Immunosuppressive therapy for RA often improves granulocytopenia and splenomegaly; this finding reflects the fact that Felty's syndrome is an immune-mediated disease. A major challenge in treating FS is a recurring infection caused by neutropenia. Therefore, in order to decide upon and begin treatment, the cause and relationship of neutropenia with the overall condition must be well understood.[8] Most of the traditional medications used to treat RA have been used in the treatment of Felty's syndrome. No well-conducted, randomized, controlled trials support the use of any single agent. Most reports on treatment regimens involve small numbers of patients. Splenectomy may improve neutropenia in severe disease. Use of rituximab and leflunomide have been proposed. Use of gold therapy has also been described.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">66. Commonest histology in lung cancer is?</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/a6d385eda05e6e35afadf3f593d07dca.png"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Small cell lung cancer (SCLC)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Non small cell lung cancer(NSCLC)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Poorly differentiated carcinoma</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Neuroendocrine </p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Non small cell lung cancer(NSCLC)<br/>Non-small cell lung cancer<br />\nAbout 85% to 90% of lung cancers are non-small cell lung cancer (NSCLC). <br />\nThere are 3 main subtypes of NSCLC<br />\nNon-small cell cancer<br />\nNon-small cell lung cancer is divided into four principal subgroups:<br />\n-Adenocarcinoma<br />\n-Squamous cell carcinoma  <br />\n-Large cell carcinoma <br />\n-NSCLC not otherwise specified (NOS). This terminology is used when the NSCLC cannot be clearly diagnosed to be of adenocarcinoma, squamous Cell Carcinoma or large cell carcinoma or some of the other rarer types of carcinoma.<br />\nThe cells in these subtypes differ in size, shape, and chemical make-up when looked at under a microscope. But they are grouped together because the approach to treatment and prognosis (outlook) are often very similar.<br />\n<br />\nFive-year survival was 65% for those in stage I and 25% for those in the remaining stages. CONCLUSIONS: Of the various histological types, the most common was squamous cell carcinoma and the least common was large cell carcinoma.<br />\n<br><a target=\"_blank\" href=\"https://www.verywellhealth.com/what-is-early-stage-lung-cancer-2249025\">https://www.verywellhealth.com/what-is-early-stage-lung-cancer-2249025</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Non small cell lung cancer(NSCLC)<br/>Non-small cell lung cancer<br />\nAbout 85% to 90% of lung cancers are non-small cell lung cancer (NSCLC). <br />\nThere are 3 main subtypes of NSCLC<br />\nNon-small cell cancer<br />\nNon-small cell lung cancer is divided into four principal subgroups:<br />\n-Adenocarcinoma<br />\n-Squamous cell carcinoma  <br />\n-Large cell carcinoma <br />\n-NSCLC not otherwise specified (NOS). This terminology is used when the NSCLC cannot be clearly diagnosed to be of adenocarcinoma, squamous Cell Carcinoma or large cell carcinoma or some of the other rarer types of carcinoma.<br />\nThe cells in these subtypes differ in size, shape, and chemical make-up when looked at under a microscope. But they are grouped together because the approach to treatment and prognosis (outlook) are often very similar.<br />\n<br />\nFive-year survival was 65% for those in stage I and 25% for those in the remaining stages. CONCLUSIONS: Of the various histological types, the most common was squamous cell carcinoma and the least common was large cell carcinoma.<br />\n<br><a target=\"_blank\" href=\"https://www.verywellhealth.com/what-is-early-stage-lung-cancer-2249025\">https://www.verywellhealth.com/what-is-early-stage-lung-cancer-2249025</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">67. A 23-year-old woman comes to the emergency department with markedly increased menstrual bleeding, gum bleeding when she brushes her teeth, and petechiae on physical examination. Physical examination is otherwise normal. The platelet count is 17,000/cumm. <br />\nWhat is the most appropriate next step in therapy?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Bone marrow biopsy.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Intravenous immunoglobulins.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Prednisone</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Antiplatelet antibodies.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Platelet transfusion.</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Prednisone<br/><p>The bleeding, in this case, is mild, meaning there is no intracranial bleeding or major GI bleeding, and the platelet is not profoundly low. Prednisone is the best initial therapy. Initiating prednisone is more important than checking for increased megakaryocytes or the presence of antiplatelet antibodies, which is characteristic of ITP. Bone marrow is rarely needed.&nbsp;</p><h4><strong style=\"color: rgb(230, 0, 0);\">Diagnostic Tests Idiopathic thrombocytopenic purpura (ITP)</strong></h4><ul><li>ITP is a diagnosis of exclusion. Occasional diagnostic tests are: Antiplatelet antibodies lack specificity, limited benefit. Ultrasound or CT scan to exclude hypersplenism Megakaryocytes are elevated in number. Bone marrow, not routine; indicated only before splenectomy Increase in mean platelet volume</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">Treatment</strong></p><p>Presentation Management</p><ul><li>No bleeding, count &gt;30,000 -No treatment</li><li>Mild bleeding, count &lt;30,000 Glucocorticoids</li><li>Severe bleeding (GI/CNS), count &lt;10,000 IVIG,</li><li>Anti-Rho (anti-D)</li><li>Recurrent episodes, steroid-dependent- Splenectomy</li><li>Splenectomy or steroids not effective Romiplostim or eltrombopag, rituximab, azathioprine, cyclosporine, mycophenolate</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">TIPS</strong></p><ol><li>ITP is a diagnosis of exclusion</li><li>ITP has no lymphadenopathy no hepatomegaly</li><li>CBC showed only low Platelet count(isolated thrombocytopenia), HB and WBC is normal</li><li>Bone marrow showed-increase number of Megakaryocytes with normal morphology</li><li>The steroid is the first-line treatment and if fails splenectomy is the best next option</li><li>Platelets are large in ITP.</li><li>Before splenectomy, give vaccination to Neisseria meningitides Haemophilus influenza Pneumococcus</li><li>Romiplostim and eltrombopag are synthetic thrombopoietins for ITP.&nbsp;</li></ol><p><br></p><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Prednisone<br/><p>The bleeding, in this case, is mild, meaning there is no intracranial bleeding or major GI bleeding, and the platelet is not profoundly low. Prednisone is the best initial therapy. Initiating prednisone is more important than checking for increased megakaryocytes or the presence of antiplatelet antibodies, which is characteristic of ITP. Bone marrow is rarely needed.&nbsp;</p><h4><strong style=\"color: rgb(230, 0, 0);\">Diagnostic Tests Idiopathic thrombocytopenic purpura (ITP)</strong></h4><ul><li>ITP is a diagnosis of exclusion. Occasional diagnostic tests are: Antiplatelet antibodies lack specificity, limited benefit. Ultrasound or CT scan to exclude hypersplenism Megakaryocytes are elevated in number. Bone marrow, not routine; indicated only before splenectomy Increase in mean platelet volume</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">Treatment</strong></p><p>Presentation Management</p><ul><li>No bleeding, count &gt;30,000 -No treatment</li><li>Mild bleeding, count &lt;30,000 Glucocorticoids</li><li>Severe bleeding (GI/CNS), count &lt;10,000 IVIG,</li><li>Anti-Rho (anti-D)</li><li>Recurrent episodes, steroid-dependent- Splenectomy</li><li>Splenectomy or steroids not effective Romiplostim or eltrombopag, rituximab, azathioprine, cyclosporine, mycophenolate</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">TIPS</strong></p><ol><li>ITP is a diagnosis of exclusion</li><li>ITP has no lymphadenopathy no hepatomegaly</li><li>CBC showed only low Platelet count(isolated thrombocytopenia), HB and WBC is normal</li><li>Bone marrow showed-increase number of Megakaryocytes with normal morphology</li><li>The steroid is the first-line treatment and if fails splenectomy is the best next option</li><li>Platelets are large in ITP.</li><li>Before splenectomy, give vaccination to Neisseria meningitides Haemophilus influenza Pneumococcus</li><li>Romiplostim and eltrombopag are synthetic thrombopoietins for ITP.&nbsp;</li></ol><p><br></p><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">68. If heparin-induced thrombocytopenia (HIT) is suspected?<br />\nclick below image to enlarge view</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/29fa285e817d1989f20afbc1f38bc6ee.jpg"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. The first step is to discontinue and avoid all heparin products immediately</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Stop IV heparin, LMWH can be continued</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Give platelet transfusion urgently when platelets are less than 10,000/cumm</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Continue heparin and do diagnostic workup</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : The first step is to discontinue and avoid all heparin products immediately<br/>HIT treatment<br />\n<br />\nGiven the fact that HIT predisposes strongly to new episodes of thrombosis, it is not sufficient to simply discontinue the heparin administration. Generally, an alternative anticoagulant is needed to suppress the thrombotic tendency while the generation of antibodies stops and the platelet count recovers. To make matters more complicated, the other most commonly used anticoagulant, warfarin, should not be used in HIT until the platelet count is at least 150 x 10^9/L because there is a very high risk of warfarin necrosis in people with HIT who have low platelet counts. Warfarin necrosis is the development of skin gangrene in those receiving warfarin or a similar vitamin K inhibitor. If the patient was receiving warfarin at the time when HIT is diagnosed, the activity of warfarin is reversed with vitamin K.Transfusing platelets is discouraged, as there is a theoretical risk that this may worsen the risk of thrombosis; the platelet count is rarely low enough to be the principal cause of significant hemorrhage.<br />\nVarious non-heparin agents are used to provide anticoagulation in those with strongly suspected or proven HIT: danaparoid, fondaparinux, bivalirudin and argatroban.These are alternatives to heparin therapy. Not all agents are available in all countries, and not all are approved for this specific use. For instance, argatroban is only recently licensed in the United Kingdom, and danaparoid is not available in the United States.[8] Fondaparinux, a Factor Xa inhibitor, is commonly used off label for HIT treatment in the United States..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : The first step is to discontinue and avoid all heparin products immediately<br/>HIT treatment<br />\n<br />\nGiven the fact that HIT predisposes strongly to new episodes of thrombosis, it is not sufficient to simply discontinue the heparin administration. Generally, an alternative anticoagulant is needed to suppress the thrombotic tendency while the generation of antibodies stops and the platelet count recovers. To make matters more complicated, the other most commonly used anticoagulant, warfarin, should not be used in HIT until the platelet count is at least 150 x 10^9/L because there is a very high risk of warfarin necrosis in people with HIT who have low platelet counts. Warfarin necrosis is the development of skin gangrene in those receiving warfarin or a similar vitamin K inhibitor. If the patient was receiving warfarin at the time when HIT is diagnosed, the activity of warfarin is reversed with vitamin K.Transfusing platelets is discouraged, as there is a theoretical risk that this may worsen the risk of thrombosis; the platelet count is rarely low enough to be the principal cause of significant hemorrhage.<br />\nVarious non-heparin agents are used to provide anticoagulation in those with strongly suspected or proven HIT: danaparoid, fondaparinux, bivalirudin and argatroban.These are alternatives to heparin therapy. Not all agents are available in all countries, and not all are approved for this specific use. For instance, argatroban is only recently licensed in the United Kingdom, and danaparoid is not available in the United States.[8] Fondaparinux, a Factor Xa inhibitor, is commonly used off label for HIT treatment in the United States..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">69. What is the usual treatment of phylloidtumour of breast?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Mastectomy or removal of tumour</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Modified radical mastectomy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Chemotherapy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Radiotherapy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Hormonal therapy alone</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Mastectomy or removal of tumour<br/>Phyllodes tumors can also be spelled phylloides tumors. These are rare breast tumors that start in the connective (stromal) tissue of the breast.<br />\nPhyllodes tumors are most common in women in their 40s, but women of any age can have them. Women with Li-Fraumeni syndrome (a rare, inherited genetic condition) have an increased risk for phyllodes tumors. <br />\nMost phyllodes tumors are benign (not cancer), but about 1 out of 4 of these tumors are malignant (cancer). <br />\n<br />\nBreast-conserving surgery (lumpectomy or partial mastectomy), in which part of the breast is removed, is typically the main treatment. Phyllodes tumors can sometimes come back in the same place if they’re removed without taking enough of the normal tissue around them. For this reason, a margin of normal breast tissue around the tumor is taken out as well. Mastectomy (removal of the entire breast) may be needed if a cancer-free margin of normal breast tissue cannot be taken out with the tumor.<br />\n<br />\nIf the phyllodes tumor is cancer, a wider area of normal tissue will be removed along with the tumor. Or the entire breast might be removed with mastectomy. Radiation therapy might be given to the area after surgery, especially if it’s not clear that all of the tumor was removed.  Malignant phyllodes tumors are different from the more common types of breast cancer. They are less likely to respond to some of the treatments commonly used for breast cancer, such as hormone therapy or the chemotherapy drugs normally used for breast cancer. Phyllodes tumors that have spread to other parts of the body are often treated more like sarcomas (soft-tissue cancers) than breast cancers.<br />\nBecause these tumors can come back, close follow-up with frequent breast exams and imaging tests are usually recommended after treatment..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Mastectomy or removal of tumour<br/>Phyllodes tumors can also be spelled phylloides tumors. These are rare breast tumors that start in the connective (stromal) tissue of the breast.<br />\nPhyllodes tumors are most common in women in their 40s, but women of any age can have them. Women with Li-Fraumeni syndrome (a rare, inherited genetic condition) have an increased risk for phyllodes tumors. <br />\nMost phyllodes tumors are benign (not cancer), but about 1 out of 4 of these tumors are malignant (cancer). <br />\n<br />\nBreast-conserving surgery (lumpectomy or partial mastectomy), in which part of the breast is removed, is typically the main treatment. Phyllodes tumors can sometimes come back in the same place if they’re removed without taking enough of the normal tissue around them. For this reason, a margin of normal breast tissue around the tumor is taken out as well. Mastectomy (removal of the entire breast) may be needed if a cancer-free margin of normal breast tissue cannot be taken out with the tumor.<br />\n<br />\nIf the phyllodes tumor is cancer, a wider area of normal tissue will be removed along with the tumor. Or the entire breast might be removed with mastectomy. Radiation therapy might be given to the area after surgery, especially if it’s not clear that all of the tumor was removed.  Malignant phyllodes tumors are different from the more common types of breast cancer. They are less likely to respond to some of the treatments commonly used for breast cancer, such as hormone therapy or the chemotherapy drugs normally used for breast cancer. Phyllodes tumors that have spread to other parts of the body are often treated more like sarcomas (soft-tissue cancers) than breast cancers.<br />\nBecause these tumors can come back, close follow-up with frequent breast exams and imaging tests are usually recommended after treatment..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">70. How to diagnose Paget disease of breast?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. It is purely a clinical diagnosis</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. USG and mammogram breast</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Biopsy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. MRI breast</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Biopsy<br/>How is Paget disease of the breast diagnosed?<br />\nA nipple biopsy allows doctors to correctly diagnose Paget disease of the breast. There are several types of nipple biopsy, including the procedures described below.<br />\n- Surface biopsy: A glass slide or other tool is used to gently scrape cells from the surface of the skin.<br />\n- Shave biopsy: A razor-like tool is used to remove the top layer of skin.<br />\n- Punch biopsy: A circular cutting tool, called a punch, is used to remove a disk-shaped piece of tissue.<br />\n- Wedge biopsy: A scalpel is used to remove a small wedge of tissue.<br />\nIn some cases, doctors may remove the entire nipple (1). A pathologist then examines the cells or tissue under a microscope to look for Paget cells..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Biopsy<br/>How is Paget disease of the breast diagnosed?<br />\nA nipple biopsy allows doctors to correctly diagnose Paget disease of the breast. There are several types of nipple biopsy, including the procedures described below.<br />\n- Surface biopsy: A glass slide or other tool is used to gently scrape cells from the surface of the skin.<br />\n- Shave biopsy: A razor-like tool is used to remove the top layer of skin.<br />\n- Punch biopsy: A circular cutting tool, called a punch, is used to remove a disk-shaped piece of tissue.<br />\n- Wedge biopsy: A scalpel is used to remove a small wedge of tissue.<br />\nIn some cases, doctors may remove the entire nipple (1). A pathologist then examines the cells or tissue under a microscope to look for Paget cells..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">71. Which test may help in diagnosing krukenbergtumours from Primary ovarian neoplasm?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. CT Scan-High resolution</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. MRI</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Immunohistochemistry</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Clinical presentation</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Immunohistochemistry<br/>A Krukenberg tumor refers to a malignancy in the ovary that metastasized from a primary site, classically the gastrointestinal tract, although it can arise in other tissues such as the breast. Gastric adenocarcinoma, especially at the pylorus, is the most common source.<br />\n<br />\nTreatment and prognosis[edit]<br />\nSince Krukenberg tumors are secondary (metastatic), management might logically be driven by identifying and treating the primary cancer. The optimal treatment of Krukenberg tumors is unclear.[2] The role of surgical resection has not been adequately addressed[2] but if metastasis is limited to the ovaries, surgery may improve survival.[2][8][9] The role of chemotherapy and/or radiotherapy is uncertain[2] but may sometimes be beneficial.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Immunohistochemistry<br/>A Krukenberg tumor refers to a malignancy in the ovary that metastasized from a primary site, classically the gastrointestinal tract, although it can arise in other tissues such as the breast. Gastric adenocarcinoma, especially at the pylorus, is the most common source.<br />\n<br />\nTreatment and prognosis[edit]<br />\nSince Krukenberg tumors are secondary (metastatic), management might logically be driven by identifying and treating the primary cancer. The optimal treatment of Krukenberg tumors is unclear.[2] The role of surgical resection has not been adequately addressed[2] but if metastasis is limited to the ovaries, surgery may improve survival.[2][8][9] The role of chemotherapy and/or radiotherapy is uncertain[2] but may sometimes be beneficial.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">72. Treatment of krukenberg tumors of ovary?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Remove ovary</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Identify and treat primary</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Chemotherapy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Radiotherapy</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Identify and treat primary<br/>B since Krukenberg tumors are secondary (metastatic), management might logically be driven by identifying and treating the primary cancer. The optimal treatment of Krukenberg tumors is unclear. The role of surgical resection has not been adequately addressed, but if metastasis is limited to the ovaries, surgery may improve survival.The role of chemotherapy and/or radiotherapy is uncertain but may be sometimes be beneficial..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Identify and treat primary<br/>B since Krukenberg tumors are secondary (metastatic), management might logically be driven by identifying and treating the primary cancer. The optimal treatment of Krukenberg tumors is unclear. The role of surgical resection has not been adequately addressed, but if metastasis is limited to the ovaries, surgery may improve survival.The role of chemotherapy and/or radiotherapy is uncertain but may be sometimes be beneficial..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">73. Most significant contraindication for Fine Needle Aspiration biopsy (FNA) is:</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Bleeding disorder</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Disseminated malignancy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Moribund state of the patient</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. HIV positivity</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Bleeding disorder<br/>Absolute Contraindications:<br />\nAny coagulation disorder (coagulopathy, any disease that the patient bleeds more easily)<br />\nUse of anticoagulants (medication that can cause unwanted bleeding as a side effect).<br />\nRelative Contraindications:<br />\nEmphysematous lung (disease that usually relates to patient who smokes too much,), because it can cause pneumothorax (air in the pleural cavity that is outside the lungs)<br />\nPulmonary arterial hypertension can cause hemorrhage (bleeding)<br />\nCarotid sinus tumors (bleeding may occur)<br />\nPheochromocytoma (adrenal tumors) that can be manipulated to release adrenalin in the blood stream, causing hypertensive crises – sudden increase of blood pressure..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Bleeding disorder<br/>Absolute Contraindications:<br />\nAny coagulation disorder (coagulopathy, any disease that the patient bleeds more easily)<br />\nUse of anticoagulants (medication that can cause unwanted bleeding as a side effect).<br />\nRelative Contraindications:<br />\nEmphysematous lung (disease that usually relates to patient who smokes too much,), because it can cause pneumothorax (air in the pleural cavity that is outside the lungs)<br />\nPulmonary arterial hypertension can cause hemorrhage (bleeding)<br />\nCarotid sinus tumors (bleeding may occur)<br />\nPheochromocytoma (adrenal tumors) that can be manipulated to release adrenalin in the blood stream, causing hypertensive crises – sudden increase of blood pressure..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">74. What is the most common type of breast cancer?<br />\nclick below image to enlarge view</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/9c2ec774d6ed53b402458944e66131e9.png"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Ductal carcinoma in situ (DCIS)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Invasive lobular carcinoma (ILC)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Invasive ductal carcinoma (IDC)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Paget's disease</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Invasive ductal carcinoma (IDC)<br/>Invasive ductal carcinoma (IDC), sometimes called infiltrating ductal carcinoma, is the most common type of breast cancer. About 80% of all breast cancers are invasive ductal carcinomas.<br />\nInvasive means that the cancer has “invaded” or spread to the surrounding breast tissues. Ductal means that the cancer began in the milk ducts, which are the “pipes” that carry milk from the milk-producing lobules to the nipple..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Invasive ductal carcinoma (IDC)<br/>Invasive ductal carcinoma (IDC), sometimes called infiltrating ductal carcinoma, is the most common type of breast cancer. About 80% of all breast cancers are invasive ductal carcinomas.<br />\nInvasive means that the cancer has “invaded” or spread to the surrounding breast tissues. Ductal means that the cancer began in the milk ducts, which are the “pipes” that carry milk from the milk-producing lobules to the nipple..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">75. Which of the following conditions is associated with increased risk of breast cancer?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Atypical hyperplasia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Severe hyperplasia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Fibrocystic mastopathy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Papillomatosis</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Atypical hyperplasia.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Atypical hyperplasia.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">76. Which parameter is used in ultrasonography of cervical nodes for distinguishing benign from malignant nodes?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Area</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Volume</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Ratio of long to short axis (L / S ratio)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Sonodensity</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Ratio of long to short axis (L / S ratio)<br/>Benign nodes have been found to have a long-axis diameter at least 2 times the short-axis diameter, with a shape index of less than 0.5, corresponding to an oval shape. Malignant nodes have been found to have a shape index of greater than 0.5, corresponding to a more rounded shape..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Ratio of long to short axis (L / S ratio)<br/>Benign nodes have been found to have a long-axis diameter at least 2 times the short-axis diameter, with a shape index of less than 0.5, corresponding to an oval shape. Malignant nodes have been found to have a shape index of greater than 0.5, corresponding to a more rounded shape..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">77. Which one of the following is not used as a tumor marker in testicular tumors?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. HCG</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. AFP</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. LDH</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. CEA</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : CEA<br/>CEA <br />\nINTRODUCTION<br />\nTesticular cancers germ cell tumors (GCTs) have become one of the most curable solid neoplasms, due to remarkable treatment advances that began in the late 1970s. Prior to that time, testicular cancer accounted for 11 percent of cancer deaths in men between the ages of 25 to 34, and the five-year survival rate was 64 percent [1]. Currently, the five-year survival rate is over 95 percent, largely due to better understanding of the natural history of testicular tumors, improved staging and surgical techniques, the use of effective platinum-based combination chemotherapy, and the availability of highly sensitive serum tumor markers to detect minimal residual disease. Three serum tumor markers have established roles in the management of men with testicular germ cell tumors:<br />\n-The beta subunit of human chorionic gonadotropin (beta-hCG)<br />\n-Alpha fetoprotein (AFP)<br />\n-Lactate dehydrogenase (LDH).</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : CEA<br/>CEA <br />\nINTRODUCTION<br />\nTesticular cancers germ cell tumors (GCTs) have become one of the most curable solid neoplasms, due to remarkable treatment advances that began in the late 1970s. Prior to that time, testicular cancer accounted for 11 percent of cancer deaths in men between the ages of 25 to 34, and the five-year survival rate was 64 percent [1]. Currently, the five-year survival rate is over 95 percent, largely due to better understanding of the natural history of testicular tumors, improved staging and surgical techniques, the use of effective platinum-based combination chemotherapy, and the availability of highly sensitive serum tumor markers to detect minimal residual disease. Three serum tumor markers have established roles in the management of men with testicular germ cell tumors:<br />\n-The beta subunit of human chorionic gonadotropin (beta-hCG)<br />\n-Alpha fetoprotein (AFP)<br />\n-Lactate dehydrogenase (LDH).</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">78. Which of the following is not associated with malignancy?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Fragile x syndrome</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Fanconi’s syndrome</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Down’s syndrome</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Bloom syndrome</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Fragile x syndrome<br/>fragile x syndrome is not associated with malignancy.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Fragile x syndrome<br/>fragile x syndrome is not associated with malignancy.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">79. Which of the following breast lesions are noninvasive malignancies?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Intraductal carcinoma of the comedo type</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Medullary carcinoma, including atypical medullary lesions</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Tubular carcinoma </p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Mucinous carcinoma</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Intraductal carcinoma of the comedo type<br/>Comedocarcinoma is one kind of breast cancer which is most commonly very early-stage[1][2] which demonstrates central necrosis.[3] It is usually a type of ductal carcinoma in situ. Comedo carcinomas are usually non-infiltrating and intraductal tumors. However, there have been accounts of comedocarcinoma which has then diversified into other cell types and developed into infiltrating (invasive) ductal carcinoma.[4] Recurrence and survival rates differ for invasive breast cancer which has originated as comedocarcinoma compared with other types of cancer cells.[5] <br />\nThe duct will have characteristic necrotic tissue with calcification that feels cord-like. Squeezing the duct will yield inspissated material that is cheese-like and similar in consistency to toothpaste. <br />\nComedocarcinoma has also been described as a histopathological type of Sebaceous carcinoma.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Intraductal carcinoma of the comedo type<br/>Comedocarcinoma is one kind of breast cancer which is most commonly very early-stage[1][2] which demonstrates central necrosis.[3] It is usually a type of ductal carcinoma in situ. Comedo carcinomas are usually non-infiltrating and intraductal tumors. However, there have been accounts of comedocarcinoma which has then diversified into other cell types and developed into infiltrating (invasive) ductal carcinoma.[4] Recurrence and survival rates differ for invasive breast cancer which has originated as comedocarcinoma compared with other types of cancer cells.[5] <br />\nThe duct will have characteristic necrotic tissue with calcification that feels cord-like. Squeezing the duct will yield inspissated material that is cheese-like and similar in consistency to toothpaste. <br />\nComedocarcinoma has also been described as a histopathological type of Sebaceous carcinoma.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">80. A low hemoglobin, normal MCV, and high reticulocyte count would support a diagnosis of:</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Alcoholism</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Myelofibrosis</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Thalassemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Folate deficiency</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Bleeding</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is E : Bleeding<br/>Bleeding and hemolysis showed low hemoglobin with high reticulocyte count with normal MCV..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is E : Bleeding<br/>Bleeding and hemolysis showed low hemoglobin with high reticulocyte count with normal MCV..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">81. Percent transferrin saturation is calculated by?</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/c96ff088b1e2e4d8e44135f5ff32c0fc.jpg"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. (TIBC x 100) ÷ Serum iron</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. (Serum iron + TIBC) ÷ 100</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. (Serum iron + 100) ÷ TIBC</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Serum iron ÷ TIBC x 100</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : Serum iron ÷ TIBC x 100<br/>Percent transferrin saturation is derived by dividing serum iron level (x 100) by TIBC. Normal transferrin saturation ranges from 25 - 50 %.<br />\nLess than 20% Transferrin saturation suggest-IDA<br />\nMore than 50% in male and more than 40% in female suggest -iron overload..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : Serum iron ÷ TIBC x 100<br/>Percent transferrin saturation is derived by dividing serum iron level (x 100) by TIBC. Normal transferrin saturation ranges from 25 - 50 %.<br />\nLess than 20% Transferrin saturation suggest-IDA<br />\nMore than 50% in male and more than 40% in female suggest -iron overload..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">82. Which of the following is complication of B12 or folate replacement.</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Seizures</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Hemolysis</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Hypokalemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Hyperkalemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Diarrhea</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Hypokalemia<br/>Vitamin B12 is considered safe, even at levels much higher than the recommended dose. It has not been shown to be toxic or cause cancer, birth defects, or mutations.10,75 Be aware, however, that patients who have a vitamin B12 deficiency with associated megaloblastic anemia might experience hypokalemia and fluid overload early in treatment due to increased erythropoiesis, cellular uptake of potassium, and increased blood volume..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Hypokalemia<br/>Vitamin B12 is considered safe, even at levels much higher than the recommended dose. It has not been shown to be toxic or cause cancer, birth defects, or mutations.10,75 Be aware, however, that patients who have a vitamin B12 deficiency with associated megaloblastic anemia might experience hypokalemia and fluid overload early in treatment due to increased erythropoiesis, cellular uptake of potassium, and increased blood volume..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">83. A 52-year-old smoker has a 1.5-cm calcified nodule found on a chest x-ray done for other reasons. He has no symptoms. What should you do?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Excisional Biopsy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. CT scan</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. PET CT scan</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Bone scan</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Mutation Analysis</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Excisional Biopsy<br/><p>Excisional biopsy should be done on solitary lung nodules &gt; 1 cm in size in patients who are smokers. Age &gt; 50 lends additional urgency to the need for biopsy. Even though calcification goes against malignancy, the age of the patient, size of the nodule, and history of smoking are more important.</p><p><br></p><p>Notes</p><ul><li>Lung cancer screening should be performed in all smokers with more than 30 pack-years of smoking history between the ages of 55–75. </li><li>A chest CT should be performed. Screen long-term smokers with chest CT at age 55.</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">Lung cancer screening: </strong></p><ol><li><strong style=\"color: rgb(230, 0, 0);\">Age 55–80 ,</strong></li><li><span style=\"color: rgb(230, 0, 0);\">30 pack-years</span></li><li><span style=\"color: rgb(230, 0, 0);\"> Annual, chest CT </span></li><li><span style=\"color: rgb(230, 0, 0);\">Has not quit in past 15 years</span></li></ol><p>Treatment</p><p>The most important issue in the treatment of lung cancer is whether the disease is localized enough to be surgically resectable. Surgery cannot be performed if any of the following are present:</p><ul><li>Bilateral disease </li><li>Metastases </li><li>Malignant pleural effusion Involvement of the aorta, vena cava, or heart </li><li>Lesions within 1–2 cm of the carina </li><li>Laryngeal nerve involvement</li></ul><p><br></p><p><span style=\"color: rgb(230, 0, 0);\">Small-cell cancer is nonresectable</span> because one of these features is present in &gt; 95 percent of cases. The size of the lesion alone is not the reason a cancer may be unresectable. If the lesion is large but is peripheral, without metastases, it can be resected.</p><p><br></p><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Excisional Biopsy<br/><p>Excisional biopsy should be done on solitary lung nodules &gt; 1 cm in size in patients who are smokers. Age &gt; 50 lends additional urgency to the need for biopsy. Even though calcification goes against malignancy, the age of the patient, size of the nodule, and history of smoking are more important.</p><p><br></p><p>Notes</p><ul><li>Lung cancer screening should be performed in all smokers with more than 30 pack-years of smoking history between the ages of 55–75. </li><li>A chest CT should be performed. Screen long-term smokers with chest CT at age 55.</li></ul><p><strong style=\"color: rgb(230, 0, 0);\">Lung cancer screening: </strong></p><ol><li><strong style=\"color: rgb(230, 0, 0);\">Age 55–80 ,</strong></li><li><span style=\"color: rgb(230, 0, 0);\">30 pack-years</span></li><li><span style=\"color: rgb(230, 0, 0);\"> Annual, chest CT </span></li><li><span style=\"color: rgb(230, 0, 0);\">Has not quit in past 15 years</span></li></ol><p>Treatment</p><p>The most important issue in the treatment of lung cancer is whether the disease is localized enough to be surgically resectable. Surgery cannot be performed if any of the following are present:</p><ul><li>Bilateral disease </li><li>Metastases </li><li>Malignant pleural effusion Involvement of the aorta, vena cava, or heart </li><li>Lesions within 1–2 cm of the carina </li><li>Laryngeal nerve involvement</li></ul><p><br></p><p><span style=\"color: rgb(230, 0, 0);\">Small-cell cancer is nonresectable</span> because one of these features is present in &gt; 95 percent of cases. The size of the lesion alone is not the reason a cancer may be unresectable. If the lesion is large but is peripheral, without metastases, it can be resected.</p><p><br></p><p><br></p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">84. 23 year female consulted her physician because of breast mass; the mass is mobile, firm and approximately 1 cm in diameter. It is located in the upper outer quadrant of the right breast. No axillary lymph nodes are present. What is the treatment of choice for this condition?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Modified radical mastectomy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Lumpectomy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Biopsy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Radical mastectomy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Watchful waiting</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is E : Watchful waiting.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is E : Watchful waiting.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">85. 35 yearlady complaining of breast tenderness and diffuses nodularity, during the physical examination you found 3 cm tender mobile right side mass, what you will do next?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. FNA with cytology</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Mammogram</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Biopsy</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Follow up for next cycle</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Observation</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : FNA with cytology.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : FNA with cytology.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">86. The management of breast engorgement:</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Warm compression with continue breast feeding</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Cold compression with stoppage of breast feeding</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Cloxacillin with continue breast feeding</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Warm compression with continue breast feeding.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Warm compression with continue breast feeding.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">87. 50 year female with breast cancer ,now in remission she did age appropriate screening test.she came with many blood test along with  CA125 which was elevate, so elevation of tumor marker CA 125 is likely due to?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Breast cancer</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Associate with ovarian cancer</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Due to old age</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Normal variation</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Associate with ovarian cancer<br/>CA125.tumor marker mostly used for ovarian Cancer, but it's also used with endometrial, fallopian,breast& GIT Cancer.<br />\nMost tumor markers helps in suspecting cancer.any tumor markers is not diagnostic for any condition,if tumor markers are elevated at time of diagnosis they can be helpful in followup and helps in knowing the response of treatment of the cancer.<br />\n<br />\nmany a time tumor markers are normal but patient has advance stage malignancy.normal CA 125 doesnot ruleout ovarian cancer..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Associate with ovarian cancer<br/>CA125.tumor marker mostly used for ovarian Cancer, but it's also used with endometrial, fallopian,breast& GIT Cancer.<br />\nMost tumor markers helps in suspecting cancer.any tumor markers is not diagnostic for any condition,if tumor markers are elevated at time of diagnosis they can be helpful in followup and helps in knowing the response of treatment of the cancer.<br />\n<br />\nmany a time tumor markers are normal but patient has advance stage malignancy.normal CA 125 doesnot ruleout ovarian cancer..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">88. Lactating women with mastitis:</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Continue lactation</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Clean with alcohol</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Surgical drainage</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Continue lactation.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Continue lactation.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">89. Which of the following colon cancer screening methods lowers mortality the most?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Colonoscopy every 10 years</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Sigmoidoscopy every 5 years.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Fecal immunochemical test every year.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Fecal occult blood test (FOBT) every year</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. CT colonography (“virtual colonoscopy”).\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">F. Fecal immunochemical test (FIT) for DNA.</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Colonoscopy every 10 years<br/><p>Because 40 percent of colon cancer occurs proximal to the sigmoid colon, colonoscopy is clearly the most accurate test for detection. If the question had said “Which of the following screening methods finds colon cancer and lowers mortality?”, the answer would be “All of them.” But this is not a very exam-like question: USMLE avoids both “All of the above” and “None of the above” as answer options.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Colonoscopy every 10 years<br/><p>Because 40 percent of colon cancer occurs proximal to the sigmoid colon, colonoscopy is clearly the most accurate test for detection. If the question had said “Which of the following screening methods finds colon cancer and lowers mortality?”, the answer would be “All of them.” But this is not a very exam-like question: USMLE avoids both “All of the above” and “None of the above” as answer options.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">90. Most common malignant orbital tumor in children is?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Acute myeloid leukemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Acute lymphoblastic leukemia</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Rhabdomyosarcoma</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Cavernous hemangioma</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Dermoid cyst</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Rhabdomyosarcoma<br/>Rhabdomyosarcoma<br />\nMost common malignant orbital tumor in children is rhabdomyosarcoma.<br />\nMost common benign orbital tumor in children is dermoid cyst..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Rhabdomyosarcoma<br/>Rhabdomyosarcoma<br />\nMost common malignant orbital tumor in children is rhabdomyosarcoma.<br />\nMost common benign orbital tumor in children is dermoid cyst..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">91. Which of the following is seen in Burkitt’s lymphoma?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. t(8:14)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. t(15:17)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. t(X:18)</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. t(11:14)</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : t(8:14)<br/>t(8:14) is the most common (70% of cases) translocation seen in Burkitt’s lymphoma.<br />\nBurkitt lymphoma is a form of non-Hodgkin's lymphoma in which cancer starts in immune cells called B-cells. Recognized as a fast growing human tumor, Burkitt lymphoma is associated with impaired immunity and is rapidly fatal if left untreated. However, intensive chemotherapy can achieve long-term survival in more than half the people with Burkitt lymphoma.<br />\n<br />\nBurkitt lymphoma is named after British surgeon Denis Burkitt, who first identified this unusual disease in 1956 among children in Africa. In Africa, Burkitt lymphoma is common in young children who also have malaria and Epstein-Barr, the virus that causes infectious mononucleosis. One mechanism may be that malaria weakens the immune system's response to Epstein-Barr, allowing it to change infected B-cells into cancerous cells. About 98% of African cases are associated with Epstein-Barr infection.<br />\n<br><a target=\"_blank\" href=\"https://www.webmd.com/cancer/lymphoma/burkitt-lymphoma-prognosis-diagnosis-treatments#1\">https://www.webmd.com/cancer/lymphoma/burkitt-lymphoma-prognosis-diagnosis-treatments#1</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : t(8:14)<br/>t(8:14) is the most common (70% of cases) translocation seen in Burkitt’s lymphoma.<br />\nBurkitt lymphoma is a form of non-Hodgkin's lymphoma in which cancer starts in immune cells called B-cells. Recognized as a fast growing human tumor, Burkitt lymphoma is associated with impaired immunity and is rapidly fatal if left untreated. However, intensive chemotherapy can achieve long-term survival in more than half the people with Burkitt lymphoma.<br />\n<br />\nBurkitt lymphoma is named after British surgeon Denis Burkitt, who first identified this unusual disease in 1956 among children in Africa. In Africa, Burkitt lymphoma is common in young children who also have malaria and Epstein-Barr, the virus that causes infectious mononucleosis. One mechanism may be that malaria weakens the immune system's response to Epstein-Barr, allowing it to change infected B-cells into cancerous cells. About 98% of African cases are associated with Epstein-Barr infection.<br />\n<br><a target=\"_blank\" href=\"https://www.webmd.com/cancer/lymphoma/burkitt-lymphoma-prognosis-diagnosis-treatments#1\">https://www.webmd.com/cancer/lymphoma/burkitt-lymphoma-prognosis-diagnosis-treatments#1</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">92. Which of the following are vitamin K dependant clotting factors?</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/4e453ab161287898502820bc04fcd238.png"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. II and IV</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. IX and X</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. III and V</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. VI and VII</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : IX and X<br/>IX and X<br />\nVitamin K dependant clotting factors are II, VII, IX and X. Vitamin K is required for the gamma carboxylation of glutamic acid residues..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : IX and X<br/>IX and X<br />\nVitamin K dependant clotting factors are II, VII, IX and X. Vitamin K is required for the gamma carboxylation of glutamic acid residues..</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">93. Which of the following screening tests lowers mortality the most?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Mammography above age 50.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Mammography above age 40.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Colonoscopy.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Pap smear</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Prostate-specific antigen (PSA)</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Mammography above age 50.<br/><p>Mammography above age 50 lowers mortality the most. Although screening should start at the age of 50, the mortality benefit is also greatest above the age of 50, because the number of cases of cancer detected will be greater above the age of 50. The age cutoff for mammography is somewhat controversial. </p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Mammography above age 50.<br/><p>Mammography above age 50 lowers mortality the most. Although screening should start at the age of 50, the mortality benefit is also greatest above the age of 50, because the number of cases of cancer detected will be greater above the age of 50. The age cutoff for mammography is somewhat controversial. </p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">94. False regarding Bernard Soulier Syndrome (BSS)?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Large platelets</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Decreased platelet count</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Ristocetin aggregation normal</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Platelet aggregation in response to collagen and ADP is normal</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : Ristocetin aggregation normal<br/>Ristocetin aggregation normal<br />\nBernard-Soulier syndrome (BSS) is one of a group of hereditary platelet disorders characterized by thrombocytopenia, giant platelets, and a tendency toward bleeding<br />\nDiagnosis<br />\nThe following diagnostic studies may be helpful:<br />\n- Complete blood count (CBC), including peripheral smear (showing giant platelets)<br />\n- Bleeding time (usually prolonged)<br />\n- Platelet aggregation studies (platelets do not aggregate in response to ristocetin but do have normal aggregation in response to adenosine diphosphate, epinephrine, and collagen)<br />\n- Flow cytometry<br />\n- http://emedicine.medscape.com/article/954877-overview<br />\n- In Bernard Soulier Syndrome, platelet response to ADP, collagen and Thrombin are normal.<br />\n- But no aggregation occurs in response to Ristocetin.<br />\n- It occurs due to defect in glycoprotein Ib – the receptor for von Willebrand factor.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : Ristocetin aggregation normal<br/>Ristocetin aggregation normal<br />\nBernard-Soulier syndrome (BSS) is one of a group of hereditary platelet disorders characterized by thrombocytopenia, giant platelets, and a tendency toward bleeding<br />\nDiagnosis<br />\nThe following diagnostic studies may be helpful:<br />\n- Complete blood count (CBC), including peripheral smear (showing giant platelets)<br />\n- Bleeding time (usually prolonged)<br />\n- Platelet aggregation studies (platelets do not aggregate in response to ristocetin but do have normal aggregation in response to adenosine diphosphate, epinephrine, and collagen)<br />\n- Flow cytometry<br />\n- http://emedicine.medscape.com/article/954877-overview<br />\n- In Bernard Soulier Syndrome, platelet response to ADP, collagen and Thrombin are normal.<br />\n- But no aggregation occurs in response to Ristocetin.<br />\n- It occurs due to defect in glycoprotein Ib – the receptor for von Willebrand factor.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">95. True statement regarding platelet function defects?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Normal platelet count with increased bleeding time</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Decreased platelet count with increased bleeding time</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Increased platelet count with increased bleeding time</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Normal platelet count with normal bleeding time</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Normal platelet count with increased bleeding time<br/>Normal platelet count with increased bleeding timeIn platelet function defects, there is normal platelet count with increased bleeding time.The defect lies in platelet function, not number.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Normal platelet count with increased bleeding time<br/>Normal platelet count with increased bleeding timeIn platelet function defects, there is normal platelet count with increased bleeding time.The defect lies in platelet function, not number.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">96. HbH in alpha thalassemia is seen in which of the following conditions?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Deletion of 3 beta genes</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Deletion of 3 alpha genes</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Deletion of 4 beta genes</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Deletion of 4 alpha genes</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is B : Deletion of 3 alpha genes<br/>Hemoglobin H disease (HbH) is a form of alpha thalassemia in which moderately severe anemia develops due to reduced formation of alpha globin chains. In this condition, as in the other forms of thalassemia, there is an imbalance of globin chains needed to form hemoglobin. Normally, there are four genes to produce alpha globin chains. When three out of four of these genes become inactive, there are too few alpha globin chains to combine with beta chains and give rise to normal hemoglobin (hemoglobin A). The excess beta globin chains then combine with each other to form hemoglobin H, which is the origin of the name \"hemoglobin H disease<br />\nhttp://thalassemia.com/treatment-HbH-Lal.aspx#gsc.tab=0<br />\nDeletion of 3 alpha genes<br />\nHbH is formed by 4 beta chains (tetramer of beta chains)<br />\nIt is seen in alpha thalassemia with deletion of 3 alpha chains<br />\nIt is precipitated as Heinz bodies within RBC’s<br />\nDeletion of 4 alpha chains results in formation of HbBarts (gamma chain tetramer) and is incompatible with life.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is B : Deletion of 3 alpha genes<br/>Hemoglobin H disease (HbH) is a form of alpha thalassemia in which moderately severe anemia develops due to reduced formation of alpha globin chains. In this condition, as in the other forms of thalassemia, there is an imbalance of globin chains needed to form hemoglobin. Normally, there are four genes to produce alpha globin chains. When three out of four of these genes become inactive, there are too few alpha globin chains to combine with beta chains and give rise to normal hemoglobin (hemoglobin A). The excess beta globin chains then combine with each other to form hemoglobin H, which is the origin of the name \"hemoglobin H disease<br />\nhttp://thalassemia.com/treatment-HbH-Lal.aspx#gsc.tab=0<br />\nDeletion of 3 alpha genes<br />\nHbH is formed by 4 beta chains (tetramer of beta chains)<br />\nIt is seen in alpha thalassemia with deletion of 3 alpha chains<br />\nIt is precipitated as Heinz bodies within RBC’s<br />\nDeletion of 4 alpha chains results in formation of HbBarts (gamma chain tetramer) and is incompatible with life.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">97. Most suitable treatment of choice for advance adenocarcinoma of Lung</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Gefitinib</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Imatinib</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Sunitinib</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Sorafenib</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is A : Gefitinib<br/>Gefitinib-Gefitinib is a treatment for non small cell lung cancer (NSCLC) that has spread into the surrounding tissues (locally advanced) or to other parts of the body.<br />\n<br />\nGefitinib is also used in clinical trials for other cancer types.<br />\n<br />\nHow it works<br />\nGefitinib is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI). Tyrosine kinase is a protein that sends signals telling cancer cells to grow. Gefitinib bocks these signals. <br />\n<br />\nFor gefitinib to work the cancer cells need to have receptors for a protein called epidermal growth factor (EGFR). Your doctor will test the cancer cells for this. <br />\n<br />\n<br />\n<br />\n<br />\n<br />\n<br />\n<br><a target=\"_blank\" href=\"https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/gefitinib\">https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/gefitinib</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is A : Gefitinib<br/>Gefitinib-Gefitinib is a treatment for non small cell lung cancer (NSCLC) that has spread into the surrounding tissues (locally advanced) or to other parts of the body.<br />\n<br />\nGefitinib is also used in clinical trials for other cancer types.<br />\n<br />\nHow it works<br />\nGefitinib is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI). Tyrosine kinase is a protein that sends signals telling cancer cells to grow. Gefitinib bocks these signals. <br />\n<br />\nFor gefitinib to work the cancer cells need to have receptors for a protein called epidermal growth factor (EGFR). Your doctor will test the cancer cells for this. <br />\n<br />\n<br />\n<br />\n<br />\n<br />\n<br />\n<br><a target=\"_blank\" href=\"https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/gefitinib\">https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/gefitinib</a>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">98. A 42-year-old woman has a 2-cm breast cancer tumor removed by lumpectomy, and the breast is irradiated. The cancer is negative for estrogen receptors and positive for progesterone receptors. Three of 14 nodes removed from the axilla are positive for cancer. What is the next best step in management?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Adjuvant chemotherapy and radiation of the axilla.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Tamoxifen for 5 years.</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. Anastrozole (aromatase inhibitor) for 5 years.\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Tamoxifen and adjuvant chemotherapy.\n</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">E. Oophorectomy and chemotherap</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is D : Tamoxifen and adjuvant chemotherapy.\n<br/><p>Tamoxifen is used whenever there are either estrogen receptors or progesterone receptors positive. If both receptors are positive, tamoxifen will be of greater benefit. Adjuvant chemotherapy is used whenever the axillary nodes are positive or the cancer is &gt; 1 cm in size.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is D : Tamoxifen and adjuvant chemotherapy.\n<br/><p>Tamoxifen is used whenever there are either estrogen receptors or progesterone receptors positive. If both receptors are positive, tamoxifen will be of greater benefit. Adjuvant chemotherapy is used whenever the axillary nodes are positive or the cancer is &gt; 1 cm in size.</p>.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">99. What is the best treatment of MGUS (Monoclonal Gammopathy of uncertain Significance)?</p>"
          },
          "image": {
            "__cdata": "https://www.medicalmcq4all.com/public/uploads/answer/ce12a5ba61b5ad024fd161596bb1cfaf.jpg"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Same as Myeloma -thalidomide, dexamethasone and or bortezomib</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Stem cell transplantation</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. No treatment, just followup</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Immunotherapy</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : No treatment, just followup<br/>MGUS there is less than 5% plasma cells,No end organ damage(means NO CRAB) only Monoclonal spike in IgG or IgA region on SPEP(Serum protein Electrophoresis).Bone marrow biopsy is required to know the plasma cells.<br />\nMonoclonal Gammopathy of Undetermined Significance (MGUS)<br />\nIt’s a condition with the excessive production of particular IGs (IgG, IgM) by plasma cells without the systemic<br />\nmanifestations of myeloma, such as bone lesions, renal failure, anemia, and hypercalcemia. It’s the most common<br />\nmonoclonal gammopathy (60%), with 1-3% prevalence in the elderly. Etiology is unknown.<br />\nEssentials of diagnosis<br />\n1. Most patients are asymptomatic and found out on random blood testing: elevated serum total proteins and IG<br />\nlevels (lower than those in myeloma); M-spike in protein electrophoresis.<br />\n2. No abnormal Ca, BUN, Hb, or lytic bone lesions. Bone marrow biopsy will show less than 5% blasts.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : No treatment, just followup<br/>MGUS there is less than 5% plasma cells,No end organ damage(means NO CRAB) only Monoclonal spike in IgG or IgA region on SPEP(Serum protein Electrophoresis).Bone marrow biopsy is required to know the plasma cells.<br />\nMonoclonal Gammopathy of Undetermined Significance (MGUS)<br />\nIt’s a condition with the excessive production of particular IGs (IgG, IgM) by plasma cells without the systemic<br />\nmanifestations of myeloma, such as bone lesions, renal failure, anemia, and hypercalcemia. It’s the most common<br />\nmonoclonal gammopathy (60%), with 1-3% prevalence in the elderly. Etiology is unknown.<br />\nEssentials of diagnosis<br />\n1. Most patients are asymptomatic and found out on random blood testing: elevated serum total proteins and IG<br />\nlevels (lower than those in myeloma); M-spike in protein electrophoresis.<br />\n2. No abnormal Ca, BUN, Hb, or lytic bone lesions. Bone marrow biopsy will show less than 5% blasts.</p>"
                },
                "button": [
                  {
                    "__cdata": "Next"
                  },
                  {
                    "__cdata": "Previous"
                  }
                ]
              }
            }
          ]
        },
        {
          "box": [
            "",
            ""
          ],
          "text": {
            "__cdata": "<p class=\"p_20\">100. All are true about Waldenstrom Macroglobinemia except?</p>"
          },
          "option": [
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">A. Over production ofIgM from malignant B cells</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">B. Hyperviscosity is commonly seen</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">C. There are extensive bone lesion</p>"
              }
            },
            {
              "text": {
                "__cdata": "<p class=\"p_16 white\">D. Initial treatment of hyperviscosity is plasmapharesis</p>"
              }
            }
          ],
          "fb": [
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Correct!</p><p>Correct answer is C : There are extensive bone lesion<br/>usually there is NO bone lesion..</p>"
                },
                "button": {
                  "__cdata": "Previous"
                }
              }
            },
            {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_20 black\">Nope!</p><p>Correct answer is C : There are extensive bone lesion<br/>usually there is NO bone lesion..</p>"
                },
                "button": {
                  "__cdata": "Previous"
                }
              }
            }
          ]
        }
      ],
      "timeout": {
        "box": {
          "box": {
            "text": {
              "__cdata": "<p class=\"p_42 grey\">Times up!</p>"
            },
            "button": {
              "__cdata": "Start again"
            }
          }
        }
      },
      "score": {
        "fb": [
          {
            "box": {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_30 white glow\">CONGRATULATIONS!</p><p class=\"p_20 orange glow\">You scored [score]%</p>"
                },
                "button": {
                  "__cdata": "Play again?"
                }
              }
            }
          },
          {
            "box": {
              "box": {
                "text": {
                  "__cdata": "<p class=\"p_32 white glow\">Bad luck! You scored [score]%</p><p class=\"p_20 orange glow\">Why not have another go?</p>"
                },
                "button": {
                  "__cdata": "Start again"
                }
              }
            }
          }
        ]
      }
    }
  }
}